AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H1835-H1862, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (43)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, M. J.
Right arrow Articles by Wilson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, M. J.
Right arrow Articles by Wilson, E.
Vol. 281, Issue 5, H1835-H1862, November 2001

INVITED REVIEW
Regulation of ion channels by protein tyrosine phosphorylation

Michael J. Davis1, Xin Wu1, Timothy R. Nurkiewicz1, Junya Kawasaki1, Peichun Gui1, Michael A. Hill2, and Emily Wilson1

1 Department of Medical Physiology, Cardiovascular Research Institute, Texas A&M University System Health Science Center, College Station, Texas 77845; and 2 Department of Human Biology, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3083, Australia


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Ion channels are regulated by protein phosphorylation and dephosphorylation of serine, threonine, and tyrosine residues. Evidence for the latter process, tyrosine phosphorylation, has increased substantially since this topic was last reviewed. In this review, we present a comprehensive summary and synthesis of the literature regarding the mechanism and function of ion channel regulation by protein tyrosine kinases and phosphatases. Coverage includes the majority of voltage-gated, ligand-gated, and second messenger-gated channels as well as several types of channels that have not yet been cloned, including store-operated Ca2+ channels, nonselective cation channels, and epithelial Na+ and Cl- channels. Additionally, we discuss the critical roles that channel-associated scaffolding proteins may play in localizing protein tyrosine kinases and phosphatases to the vicinity of ion channels.

receptor tyrosine kinase; nonreceptor tyrosine kinase; protein tyrosine phosphatase; integrins; cytoskeleton; K+ channel; Ca2+ channel; Cl- channel; ligand-gated channel; Na+ channel; receptor-activated channel; calcium release-activated current; focal adhesion; growth factors; scaffolding proteins; Src; Fyn; Lck; Hck; A kinase-associated protein; PDZ; SH2; SH3; CFTR; MAGUK


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

ION CHANNELS ARE TARGETS of many intracellular signaling pathways, including protein phosphorylation and dephosphorylation. These processes can modify channel activity and dramatically alter the electrophysiological properties of both excitable and nonexcitable cells. Two well-known examples of this type of regulation are the L-type Ca2+ channel and the large conductance Ca2+-dependent K+ (maxi-KCa) channel, proteins that often have opposing physiological functions (157). The L-type Ca2+ channel is the primary voltage-dependent Ca2+-influx pathway in many excitable cells. Its pore-forming subunit, alpha 1C, contains NH2- and COOH-terminal cytosolic domains that are potential targets for protein phosphorylation. For example, in cardiac myocytes, activation of beta 1-adrenergic receptors leads to an increase in cytosolic cAMP, which activates the serine-threonine kinase protein kinase A (PKA). PKA phosphorylates Ser1928 of the alpha 1C COOH-terminus, shifting the voltage activation of the Ca2+ channel toward more negative potentials and producing an enhancement in whole cell L-type Ca2+ current (62). The resulting increase in Ca2+ influx contributes to the chronotropy and inotropy induced by sympathetic activation of the heart (140). L-type Ca2+ current is also potentiated by agonists of endothelin, alpha 1-adrenergic, and angiotensin II receptors through an effect on another serine-threonine kinase, protein kinase C (PKC). However, the exact phosphorylation mechanisms and sites of PKC action are unclear (106). The maxi-KCa channel is also regulated by serine phosphorylation. This channel is composed of pore-forming alpha -subunits and a regulatory beta -subunit, with the COOH-termini of the alpha -subunits being cytosolic. The maxi-KCa channel is regulated by voltage in a Ca2+-dependent manner. Protein kinase G (PKG) phosphorylates the alpha -subunit at Ser1072 near the COOH-terminus (60), shifting the Ca2+ sensitivity of the channel and producing hyperpolarization (10, 23). Other putative PKG and PKC phosphorylation sites occur on the alpha -subunit COOH-terminus in splice variants of the maxi-KCa channel, which may account for the various phenotypes of the channel observed in different tissues (237).

In addition to the extensive information available about the regulation of ion channels by serine-threonine kinases (for a review, see Ref. 95), an emerging body of evidence suggests that channels are also regulated by phosphorylation on tyrosine residues (for reviews, see Refs. 104, 123, 124, 215, 240). Growth factors, which act through receptor tyrosine kinases, are known to regulate the function and expression of many proteins, including ion channels (14, 178). The literature also indicates that nonreceptor tyrosine kinases can regulate ion channels. Collectively, this evidence suggests a mechanism whereby by growth factors, cell-cell, and cell-substrate interactions acutely regulate cell function through ion channels.

The purpose of this review is to summarize the current state of this field. As will become evident, the majority of voltage-gated, ligand-gated, and second messenger-gated channels are regulated to some degree by tyrosine phosphorylation. We review the evidence to support this concept for most major classes of ion channels, making extensive use of tables to summarize the literature. We examine the probable roles of signaling pathways involving receptor and nonreceptor tyrosine kinases that would be expected to lead to channel regulation. We discuss the critical roles that channel-associated scaffolding proteins may play in localizing protein tyrosine kinases and phosphatases to the vicinity of ion channels. Finally, when possible, we speculate on the physiological significance of ion channel regulation by these processes.

Glossary


AChR   Nicotinic acetylcholine receptor
AKAP   A kinase-associated protein
AMPA    alpha -Amino-3-hydroxy-5-methyl-4-isoxazole proprionate
BDNF   Brain-derived neurotrophic factor
BKCa channel   Large (big) conductance KCa channel
bRET   Bovine rod channel
[Ca2+]i   Intracellular Ca2+ concentration
CaM   Calmodulin
Cav channel   Voltage-activated Ca2+ channel
CFTR   Cystic fibrosis transmembrane conductance regulator
ClC channel   Voltage-gated Cl- channel family
CNG channel   Cyclic nucleotide-gated channel
Csk   c-Src kinase
DEP   dsh/egl-10/pleckstrin domain
EGF   Epidermal growth factor
EGFR   EGF receptor
ENaC   Amiloride-sensitive Na+ channel
FAK   Focal adhesion kinase
FGF   Fibroblast growth factor
GABA    gamma -Amino butyric acid
GIRK channel   G protein-coupled inwardly rectifying K+ channel
GK   Guanylate cyclase
GKAP   G kinase-associated protein
GST   Glutathione-S-transferase
HEK   Human embryonic kidney (cell line)
ICRAC   Calcium release-activated current
IGF   Insulin-like growth factor
INAD   Inactivation-no-afterpotential D (protein)
Ins(1,4,5)P3   D-myo-Inositol (1,4,5)-trisphosphate
JAK2   Janus kinase 2
KATP channel   ATP-sensitive K+ channel
KCa channel   Ca2+-dependent K+ channel
Kir channel   Inwardly rectifying K+ channel
Kv channel   Voltage-gated K+ channel
MAGUK   Membrane-associated GK
MAPK   Mitogen-activated protein kinase
MDCK   Madin-Darby canine kidney (cell line)
MuSK   Muscle-specific (tyrosine) kinase
NGF   Nerve growth factor
NGFR   NGF receptor
NMDA   N-methyl-D-aspartate
NT3   Neurotrophin-3
PC12   Rat pheochromocytoma
PDGF   Platelet-derived growth factor
PDZ   PSD-95/SAPSO, Dlg, and 20-1 domain
PH   Pleckstrin homology
PKA   Protein kinase A
PKC   Protein kinase C
PKG   Protein kinase G
PLC   Phospholipase C
Po   Open probability
PTB   Phosphotyrosine binding
PTK   Protein tyrosine kinase
PTP   Protein tyrosine phosphatase
PX   Phox homology
PYK2   Pyruvate kinase 2
RACC   Receptor-activated Ca2+ channel
RPTP   Receptor PTP
RVD   Regulatory volume decrease
rOLF channel   Rat olfactory CNG channel
RPTP   Receptor PTP
SERCA   Sarco(endo)plasmic reticulum Ca2+-ATPase
SH2   Src homology 2
SH3   Src homology 3
Src   Sarcoma virus tyrosine kinase
STOC   Spontaneous transient outward current
Trp   Transient receptor potential
TTX   Tetrodotoxin
VEGF   Vascular endothelial growth factor


    RECEPTOR AND NONRECEPTOR TYROSINE KINASES
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

To provide a context for understanding how ion channels are regulated by tyrosine phosphorylation, some brief discussion of PTKs and phosphatases seems appropriate.

PTKs were initially discovered as the products of oncogenes from transforming retroviruses (91). PTKs are responsible for transducing key extracellular signals that mediate events such as proliferation, cytoskeletal rearrangement, and coordination of physiological responses. Cellular PTKs can be divided into two primary groups: receptor and nonreceptor PTKs (117).

Members of the receptor PTK family include the insulin receptor and growth factor receptors such as EGF, PDGF, FGF, IGF, and VEGF receptors. Structurally, the receptor PTKs are characterized by an extracellular ligand-binding domain, a transmembrane domain, a kinase-catalytic domain, and cytoplasmic regions responsible for organizing signaling molecules. Signal transduction is initiated by a sequence of growth factor (ligand) binding to the extracellular domain, dimerization of the receptor proteins, and autophosphorylation of the receptor. Receptor autophosphorylation creates phosphorylated tyrosine residues on the cytoplasmic tail of the receptor. These phosphorylated tyrosine residues form docking sites for signaling molecules, and it is the combination of these signaling molecules that determines the specificity of individual receptor PTKs (51).

Nonreceptor PTKs are found in both the cytoplasm and nuclei of cells. The largest family of cytoplasmic PTKs is the Src family (for a review, see Ref. 1). The Src family consists of eight members: Src, Fyn, and Yes (which are ubiquitously expressed) and Lck, Hck, Fgr, Lyn, and Blk (which exhibit a more restricted expression pattern). Src family PTKs are characterized by NH2-terminal sequences that direct myristolation or pamitoylation, resulting in membrane localization. Other sequences include a nonconserved unique domain, an SH3 domain that directs binding to polyproline-rich sequences, an SH2 domain that binds phosphotyrosine, a catalytic domain, and a short COOH-terminal tail. Regulation of Src family members is highly conserved. In particular, there are two tyrosine residues: one in the kinase domain and one in the COOH-terminal tail, whose phosphorylation state is important for Src activation. Autophosphorylation of the kinase domain tyrosine leads to increased kinase activity, whereas phosphorylation of the COOH-terminal tail region by Csk represses activity (164). Hence, activation can occur by dephosphorylation of the COOH-terminal tyrosine by a phosphatase such as RPTP or phosphorylation of the kinase domain tyrosine (69). Many stimuli, including receptor PTKs, G protein-coupled receptors, and integrins, have been implicated in Src activation, making this family of kinases a key point of integration for many signal transduction pathways. It is now clear that autophosphorylation of receptor PTKs can form binding sites on the receptor for Src family members and that these nonreceptor PTKs are important for some of the downstream signaling events initiated by receptor binding (233).

The other class of nonreceptor PTKs that is important for this discussion includes FAK and Pyk2/RAFTK (for a review, see Ref. 12). pp125FAK is a 125-kDa PTK that is discretely localized to cellular focal adhesions and has been shown to colocalize with integrins. FAK is a major substrate for integrin-dependent tyrosine phosphorylation, and, upon phosphorylation, it becomes enzymatically active and serves as a scaffold for the binding and localization of other proteins to the focal adhesion (201). Pyk2/RAFTK is characterized by a more diffuse cytoplasmic localization and can be activated by stress signals (122) and by a variety of extracellular signals that elevate [Ca2+]i. FAK and Pyk2/RAFTK exhibit ~48% amino acid identity and have a similar organization: a unique NH2-terminal region, a centrally located PTK domain, and two proline-rich regions at the COOH-terminus. Neither kinase contains SH2 or SH3 domains.

Activation of the Src family members FAK and Pyk2/RAFTK serves as a central integration mechanism for a number of extracellular signaling pathways. For example, when integrins on the cell surface are engaged, signal transduction pathways are triggered. Because integrins lack intrinsic enzymatic activity, they rely on the activation of a number of cytoplasmic signaling molecules, including FAK and Src. The two proteins are colocalized, and their interaction leads to autophosphorylation of FAK, creation of a binding site for the Src SH2 domain, and ultimately to Src activation (198). Src then serves to phosphorylate additional sites on FAK, allowing binding of other signaling molecules and scaffolding proteins (179, 200). This process leads to the assembly of complex signaling molecules at the focal adhesion site and organizes signaling events further downstream. There is increasing evidence for synergy between receptor PTKs and integrin signaling pathways. The Src-FAK pathways are thought to be key sites for the integration of signals from integrin pathways (203), and evidence for this integration with respect to ion channel regulation will be apparent in subsequent sections of this review.

PTPs are composed of two groups: one that recognizes phosphoserine, phosphothreonine, and phosphotyrosine residues and another that specifically recognizes phosphotyrosines (174, 249). The latter group can be subdivided into intracellular (nonreceptor) or receptor PTPs. PTPs have a conserved catalytic domain that recognizes the VIHCSAGXGRXG motif. Receptor PTPs contain extracellular domains with structural motifs similar to those found in cell adhesion molecules and two catalytic domains on their intracellular COOH-terminus. Nonreceptor PTPs contain only a single conserved phosphatase domain flanked by noncatalytic segments that mediate interactions with adapter molecules through specific protein-protein interaction domains (see THE CHANNEL-PROTEIN KINASE REGULATORY COMPLEX). Although much is known about the structure and function of PTPs (174), the evidence for involvement of specific PTPs in the regulation of ion channels is sparse.


    TYPES OF SUPPORTING EVIDENCE
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Initial evidence that ion channels were regulated by tyrosine phosphorylation came largely from pharmacological studies using soluble inhibitors of PTKs. Electrophysiological and molecular biology methods have subsequently provided insight into the mechanisms of channel regulation. This progression of methodology can be traced using the L-type Ca2+ channel as an example and is detailed below.

In vascular smooth muscle, broad-spectrum PTK inhibitors such as genistein and herbimycin attenuate depolarization-induced tone (64, 236) as well as myogenic tone (135, 165). Genistein inhibits the rise in [Ca2+]i induced by KCl depolarization (64), suggesting that it acts on a Ca2+ entry mechanism. Electrophysiological studies confirm that soluble PTK inhibitors block whole cell Ca2+ current (265), including studies that utilize inhibitors such as PP1 and PP2, which more specifically target certain PTKs, e.g., Src (48, 270). Other studies have employed strategies involving intracellular dialysis with antibodies or peptides directed at specific kinases. For example, L-type Ca2+ current in smooth muscle is increased by intracellular dialysis with a pipette solution containing a c-Src-activating peptide (263) or constitutively active Src (270) but is inhibited by monoclonal antibodies against c-Src (84, 270). Studies combining electrophysiological and molecular biology strategies have provided the best evidence for specific channel-kinase interactions. Expression of recombinant L-type Ca2+ channels in a mammalian cell line, along with kinase-dead Src to compete with endogenous Src, results in blockade of the otherwise potentiating action of IGF-1 on Ca2+ current (16). Subsequently, these electrophysiological data have been supported by biochemical evidence for Src-Ca2+ channel association using immunoprecipitation and GST fusion protein assays (16, 84). In addition, kinase assays show that purified Src kinase can phosphorylate L-type Ca2+ channels in vitro (16). Collectively, this combination of methods provides convincing support for the idea that the L-type Ca2+ channel is regulated by tyrosine phosphorylation.

As noted in our data tables, the majority of evidence for regulation of ion channels by tyrosine phosphorylation is based primarily on the effects of soluble PTK inhibitors. A major flaw in this evidence is that these antagonists are reported to have nonspecific effects (3), including direct interactions with channels (85, 166, 216), inhibition of serine-threonine kinases (2), interactions with Ca2+ indicators (17), and other nonkinase actions (114, 278). Thus approaches that depend solely on the use of these inhibitors must be interpreted with caution. A stronger case for regulation by tyrosine phosphorylation can be made if multiple PTK inhibitors acting through different mechanisms produce the same effect on a channel or if structurally related inactive forms are used. However, because some soluble PTK inhibitors are relatively specific for certain kinase families (e.g., herbimycin A, PP1, and PP2), the lack of an effect on a given channel may simply indicate that a certain class of PTK is not involved in regulation of that channel. Ideally, supportive evidence would be provided by an opposite effect resulting from inhibition of PTPs. Unfortunately, few selective tools are available to selectively inhibit PTPs. The most commonly used phosphatase blockers, pervanadate and sodium orthovanadate, are also inhibitory for serine-threonine phosphatases (72). The purification and use of specific PTPs and their inhibitors will obviously allow more specific testing of the role of these enzymes in ion channel regulation.

Although molecular approaches can potentially be used to pinpoint the site and mechanism of action of a specific PTK, these approaches are not without their own limitations. Expression of specific channel subunits in Xenopus oocytes or in mammalian cell systems (e.g., HEK 293 and COS-7) can result in uncertainties about proper membrane targeting of the channel. In many cases, the complete array of functions for accessory subunits are unknown, so that it cannot be determined a priori which channel subunits need to be expressed. Some expression systems may not possess the adequate intracellular signaling machinery to reconstitute a specific PTK-ion channel regulatory pathway. Also, some channels may undergo posttranslational processing in native cells to alter associations between channel subunits (63), but this processing may not be possible in recombinant expression systems due to lack of the appropriate enzymatic machinery. These inherent difficulties can lead to substantial differences in the behavior and regulation of expressed versus endogenous channels. Therefore, it is necessary to keep these limitations in mind when interpreting such studies, and the conclusions must ultimately be confirmed using the endogenous channel and PTK(s) in the native cell system.


    REGULATION OF LIGAND-GATED CHANNELS BY PTKS
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Ligand-gated ion channels are among the most precisely localized of membrane proteins through their extensive associations with specific scaffolding and cytoskeletal proteins at the postsynaptic density (207, 208). PTKs are also highly localized in this region (227). It is therefore not surprising that several types of ligand-gated channels are associated with, and/or regulated by, PTKs. We will review the evidence for regulation of three distinct types of ligand-gated channels by tyrosine phosphorylation. Other ligand-gated channels, or their scaffolding protein partners, are also known to be associated with PTKs (25), e.g., the AMPA receptor is associated with the nonreceptor PTK Lyn (71). However, this section will focus on those channels for which there is the best functional evidence for this type of regulation (see Table 1).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Ligand-gated channels

AChR

AChR is a neurotransmitter-gated ion channel that mediates the response to acetylcholine at the postsynaptic membrane of nicotinic cholinergic synapses. This receptor was one of the earliest and best-characterized ligand-gated channels due to the capability of isolating large quantities from Torpedo californica. AChR is composed of a pentameric rosette of four different membrane-spanning subunits, with the stoichiometry alpha 2beta gamma delta . Each alpha -subunit binds acetylcholine and is regulated by a number of serine-threonine kinases, including PKA and PKC (89). As early as 1984, it was demonstrated that AChR could be tyrosine phosphorylated by an endogenous PTK (90). The beta -, gamma -, and delta -subunits each contain a single tyrosine phosphorylation site on the major intracellular loop between transmembrane domains three and four. Tyrosine phosphorylation of one or more subunits increases the rate of channel desensitization (81).

Regulation of AChR localization is coordinated by a number of accessory proteins through tyrosine phosphorylation events. During synaptogenesis, the neurally released factor agrin causes the clustering of AChRs. Agrin is an extracellular heparin sulfate proteoglycan capable of binding growth factors (36) and, along with at least one accessory protein, stimulates the muscle-specific receptor PTK MuSK. The beta -subunit of AChR is tyrosine phosphorylated by MuSK or by an intermediate PTK, perhaps Fyn or Src (59), through a process involving one or more scaffolding proteins, including rapsyn (36). The gamma - and delta -subunits of AChR are also tyrosine phosphorylated (89). Fyn and Fyk PTKs are known to associate through their SH2 domains with the YFNI sequence of the delta -subunit (228). Of note, tyrosine phosphorylation of the delta -subunit results in its association with the adaptor protein Grb2 in the AChR complex (35). Grb2 is a key upstream player in the Ras-MAPK signaling pathway, leaving open the possibility that this pathway regulates the channel. However, the extent to which these accessory proteins and PTKs play a role in functional regulation of AChR, e.g., channel sensitization or desensitization, is not known.

NMDA Receptor

NMDA receptors are a class of glutamate receptor, the major excitatory neurotransmitter receptor in the central nervous system. NMDA receptors are composed of NR1 and NR2 subunits arranged, presumably, in a tetramer. NR1 has only a short cytoplasmic tail, but its interaction with alpha -actinin and CaM is necessary for Ca2+-dependent inactivation of the receptor (272). Each NR2(A-D) subunit has a long COOH-terminal cytoplasmic tail, at the end of which is a conserved sequence that mediates binding to the first two PDZ domains of the synaptic scaffolding protein PSD-95. This interaction appears to be important for regulation by kinases. Physiological properties of the NMDA receptor are modulated by the serine-threonine kinase PKC, although the role of subunit phosphorylation in this process is controversial (279). However, NR2A and NR2B subunits can be tyrosine phosphorylated (115), particularly NR2B (151). NR2 subunits also coimmunoprecipitate with several Src family kinases, including Src, Fyn, Yes, and Lyn (115, 232, 275). Fyn binds through its SH2 domain to the third PDZ domain of PSD-95, and Fyn-deficient mice show greatly reduced levels of NR2 phosphorylation. Heterologously expressed NMDA receptor subunits can also be phosphorylated by Src and Fyn (112, 232).

NMDA receptor currents are potentiated by PTK activation and inhibited by PTP activation (112, 253). For example, the Src-activating peptide EPQ(pY)EEIPIA applied to the intracellular surface of the NMDA receptor increases Po of the native channel in cultured neurons from the rat spinal dorsal horn (128). Another peptide containing the amino acid sequence 40-58 of Src blocks the action of EPQ(pY)EEIPIA. Po is reduced by either of two Src antibodies but increased by recombinant pp60c-Src (128, 253). Importantly, the effects of these peptides are also evident on the NMDA component of miniature excitatory postsynaptic currents (128). Further evidence for a physiological effect is the correlation between enhanced tyrosine phosphorylation of NMDA receptors and long-term potentiation (191, 192). Src and Fyn kinases lose their potentiating effect on recombinant NR1-NR2A channels if the COOH-terminus of NR2A is deleted (112). Coimmunoprecipitation of NR2 subunits and Src family kinases suggests a physical association between the receptor and the kinase (115), although intermediate kinase(s) may also be involved. Indeed, the inhibitory action of Src(40-58) peptide, which does not itself interact with the Src catalytic domain (128), points to additional protein-protein interactions required for tyrosine phosphorylation of the receptor.

GABA Receptor

GABA receptors are ligand-gated Cl- channels concentrated in the postsynaptic membrane of GABAergic synapses. The GABA receptor is a heteropentameric protein assembled from alpha -, beta -, gamma -, delta -, and rho -subunits (250). Each subunit consists of a 40- to 60-kDa polypeptide with four transmembrane regions and an extracellular COOH-terminus. Regulation of channel subunits by phosphorylation occurs at multiple sites on an intracellular loop between transmembrane segments three and four (29).

Initial studies indicated that the GABAA receptor, the most widely distributed subunit, is modulated by tyrosine phosphorylation of the gamma 2- and beta 1-subunits. GABAA receptors expressed in oocytes are inhibited by genistein and tyrphostin B-44, and this effect is associated with tyrosine phosphorylation of gamma 2- and beta 1-subunits by the nonreceptor PTK pp60c-Src (243). If alpha 1-, beta 1-, and gamma 2-subunits are expressed in HEK 293 cells along with a constitutively active form of Src, v-Src, two tyrosine residues on gamma 2 are phosphorylated and whole cell GABA current is enhanced (154). Mutation of residues Tyr365/367 to Phe365/367 on gamma 2 blocks Src-induced phosphorylation and enhancement of current. Mutation of residues Tyr384/386 to Phe384/386 on beta 1 blocks Src-induced phosphorylation without any obvious effect on current, suggesting that tyrosine phosphorylation of gamma 2 is critical to regulation (154). The function of beta 1 tyrosine phosphorylation remains to be determined. In superior cervical ganglion neurons, native GABAA channels are modulated by tyrosine kinase/phosphatase inhibitors and by dialysis with c-Src in a way consistent with physiological potentiation of GABAA current by tyrosine phosphorylation (154).

A similar regulation of GABAA is observed in spinal dorsal horn neurons. GABAA currents are reversibly inhibited by genistein but potentiated by recombinant pp60c-Src (250). Both beta 2/beta 3-subunits are tyrosine phosphorylated by an endogenous PTK(s); however, genistein appears to produce comparable inhibition of GABA current in heterologously expressed alpha 1beta 2-subunits compared with alpha 1beta 2gamma 2-subunits. This suggests that beta 2, not gamma 2, is required for this regulation (250). The functional significance of gamma 2 tyrosine phosphorylation is not yet known.

In contrast, tyrosine phosphorylation of frog melanotroph beta 2/beta 3-subunits inhibits GABA-evoked current (29). Soluble PTK inhibitors potentiate GABA currents in inside-out patches from these cells and reduce endogenous phosphorylation of beta 2/beta 3-subunits. Furthermore, single channel currents are inhibited by recombinant pp60c-Src or the PTP inhibitor sodium orthovanadate. The reasons for these disparate results (29, 250) are unknown, but they possibly reflect the actions of multiple interacting tyrosine phosphorylation events, different endogenous PTKs, phosphorylation of different GABA subunits, or involvement of different channel-associated scaffolding proteins.


    REGULATION OF K+ CHANNELS BY PTKS
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Kv Channels

Kv channels are composed of tetramers of transmembrane alpha -subunits associated with up to four beta -subunits. There are over a dozen distinct Kv alpha -subunit genes and at least three Kv beta -subunit genes with multiple alternative splice variants (43). Differential assembly and association of alpha - and beta -subunits into homo- and heterotetramers confer functional diversity to the channel. There are four main Kv subfamilies: Shaker (Kv1), Shab (Kv2), Shaw (Kv3), and Shal (Kv4). In each family, the alpha -subunit contains six membrane-spanning helices (S1-6) and a highly conserved short P loop between S5 and S6 that forms the channel conduction pathway (97). S4 is the presumed voltage sensor. S1 and S6 contain the cytosolic sequences corresponding to the NH2- and COOH-termini, respectively (42). The NH2-terminal region of S1 (130 residues) is known as the T1 domain and is the site of protein-protein interactions. Kv channel beta -subunits are intracellular proteins that play a critical role in membrane targeting of the channel and possibly confer functional properties, e.g., causing fast inactivation of the intrinsically slow inactivating alpha -subunit (101).

Initial evidence for Kv channel regulation by tyrosine phosphorylation was based on the effects of pharmacological inhibitors of tyrosine kinases and phosphatases. The evidence was obtained using a variety of native cells as well as recombinant channels in heterologous expression systems. The majority of these studies are summarized in Table 2. Our discussion focuses primarily on combined electrophysiological and molecular biology studies that provide the most compelling evidence.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Kv, Kir, KATP and KCa channels

Regulation of Shaker family Kv channels by tyrosine phosphorylation is firmly established. Coexpression of the M1 (muscarinic) AChR and the delayed rectifier K+ channel, Kv1.2, in oocytes results in suppression of K+ current after activation of the receptor (87). This inhibition is mediated by tyrosine phosphorylation of the channel subsequent to activation of PLC-beta 1 and PKC. Suppression of Kv current is relieved by mutation of a single tyrosine residue, Tyr132 to Phe132, on the NH2-terminus of the channel. This mutation reduces both basal and carbachol-induced tyrosine phosphorylation of the channel, as assessed from immunoprecipitation protocols. In contrast, mutation of another NH2-terminus site, Tyr76 to Phe76, or two potential serine phosphorylation sites for MAPK on the COOH-terminus have no effect on the inhibition caused by muscarinic agonists (87).

Coexpression of M1 AChR, Kv1.2, and EGFR in HEK 293 cells results in suppression of K+ current after receptor activation (87, 239). Application of EGF alone results in suppression of Kv1.2 current and phosphorylation of Kv1.2 by EGFR, but the "specific" EGFR kinase inhibitor tyrphostin AG1478 blocks carbachol-mediated inhibition of Kv1.2 current (239). Therefore, M1 AChR appears to transactivate EGFR to modulate the K+ channel. Because AG1478 blocks only ~50% of this response, it leaves open the possibility that other PTKs may also be involved. Indeed, in PC12 cells, another PTK responsible for phosphorylation of Kv1.2 is the nonreceptor tyrosine kinase PYK2 (122). PYK2 activity is stimulated by depolarization, by PKC, and by agonists of G protein-coupled receptors (e.g., bradykinin), all of which stimulate increases in [Ca2+]i and subsequently inhibit Kv1.2 current (122).

In T lymphocytes, Kv1.3 is tyrosine phosphorylated after stimulation of Fas (an apoptosis-related protein), which leads to apoptotic cell death. Phosphorylation appears to be mediated by the tyrosine kinase p56Lck because deficiency in that kinase abolishes inhibition of current by Fas, whereas reconstitution of p56Lck restores the effect (229). Whether Lck interacts directly with the channel has not been determined. When Kv1.3 is coexpressed in HEK 293 cells with EGFR or v-Src, the channel becomes tyrosine phosphorylated and current is suppressed by >95% (24, 78). PTK inhibitors relieve the current suppression by v-Src. The action of v-Src is not mediated by an effect on Kv1.3 expression but by modulation of channel activation and inactivation kinetics (78). On the basis of mutational analysis, regulation of Kv1.3 kinetics by Src is determined by multiple interacting phosphorylation sites, including Tyr137 on the Kv1.3 NH2-terminus and Tyr449 on the COOH-terminus (24). Interestingly, inhibition of Kv1.3 by EGF, which is predominantly through speeding of C-type inactivation, is mediated at a different site, Tyr479. Collectively, these observations imply that Kv1.3 can be differentially regulated by various PTKs.

The NH2-terminus of the human K+ channel, hKv1.5, contains a proline-rich SH3 domain known to interact with Src (79). The channel and enzyme colocalize in cell adhesion zones in the myocardium (138). Coexpression of Src and hKv1.5 in HEK 293 cells results in tyrosine phosphorylation of the channel and suppression of channel current (79). This is consistent with inhibition of Kv current by EGF in cardiac myocytes (24).

In contrast to the recombinant K+ channel studies cited above, tyrosine phosphorylation of native Kv current in mouse Schwann cells leads to current activation (219). This action is apparently mediated by the Src-family kinase p55Fyn because cell dialysis with recombinant Fyn kinase results in potentiation of a slowly inactivating K+ current component that is blocked by herbimycin A. Both Kv1.5 and Kv2.1 alpha -subunits are constitutively tyrosine phosphorylated (219). Furthermore, coimmunoprecipitation and double-labeling experiments suggest a direct association between the p55Fyn and K+ channels in these cells (219). Kv2.1 associates with Fyn through an SH2 domain (219), in contrast to Kv1.5, which associates with Src family kinases through its SH3 domain (79). The effect of tyrosine phosphorylation on K+ current in this study is noteworthy because nearly all other Kv channel studies suggest that the end result of tyrosine phosphorylation is inactivation of the channel. Sobko et al. (219) proposed that this discrepancy may be related to the absence of regulatory channel subunits in some heterologous expression systems or to the possibility that heteromultimers formed with Kv2.1 subunits in native cells confer this type of regulation by PTKs (219). In support of this idea, at least two other studies presented indirect evidence for activation of native K+ current after stimulation of receptor PTKs (104, 173, 181). It is also possible that multiple receptor and nonreceptor PTKs are involved in the normal regulation of Kv channels, e.g., Src (49, 77, 125), EGFR (239), PYK2 (122), and JAK2 (181). Resolution of these important issues may completely alter conclusions about the physiological role of Kv channel tyrosine phosphorylation.

Kir Channels

Structurally, Kir channels are composed of four alpha -subunits, each containing the S1-S6 K+ channel pore region. These subunits are lined by two transmembrane segments with intracellular NH2- and COOH-termini (194). Kir tetramers show varying degrees of inward rectification, as assessed by the current-voltage relationship of the channel. Kir1.x (ROMK) channels control K+ secretion in epithelium. Kir3.x (GIRK) channels are regulated by heterotrimeric G proteins. Kir6.x channels form octomers with sulphonylurea receptors to compose channels (KATP channels) that are regulated by intracellular ATP/ADP in a variety of tissues, notably pancreatic beta -cells. Several Kir family members are regulated by PKA and PKC in different ways and with different effects. For example, PKA-dependent phosphorylation inhibits Kir2.1 but modulates pH sensitivity in Kir1.1 (194).

Kir channels are also regulated by tyrosine phosphorylation, as summarized in Table 2. Native and recombinant Kir2.1 currents are suppressed by perorthovanadate inhibition of PTPs, and inhibition is reversed by genistein (268). Both effects are prevented by mutation of Tyr242 to Phe242 in the Kir2.1 COOH-terminus (268). When Kir2.1 is coexpressed with NGFR or EGFR, application of the appropriate ligand leads to suppression of current. Other growth factors (NT3 or BDNF) similarly suppress current, either by crossreaction with NGFR or by interaction with endogenously expressed receptor PTKs (268). Additional potential tyrosine phosphorylation sites have been identified on Kir2.1 (171), but their role in regulating the channel is not known. Tyr242 is present in other members of Kir2 at the equivalent position, so receptor PTKs have the potential to regulate other Kir2 channels by this mechanism. The equivalent tyrosine site is not found in GIRK channels (Kir3.x subfamily), but mutation of either of two other tyrosine residues in Kir3.1 (Tyr12 or Tyr67) or in Kir3.4 (Tyr32 or Tyr53) blocks BDNF-induced inhibition of current (189). The sites more proximal to the NH2-terminus appear to play the more critical role in regulating the BDNF effect. Kir3.2 channels, which lack a tyrosine residue at this site, acquire BDNF sensitivity if an Asp41 to Tyr41 mutation is made in the proximal position (189). To achieve this effect, it is also necessary to add an additional basic charge near this site, apparently to complete the general motif characteristic of PTK phosphorylation sites, i.e., charged amino acids on the NH2 side of the tyrosine and a hydrophobic residue on the COOH side (220). The specific PTK involved in regulation of Kv3.x is not known, although Kv3.1 and Src do not coimmunoprecipitate (275).

Maxi-KCa Channels

Maxi-KCa (slo) channels comprise another K+ channel family. Each channel is composed of alpha - and beta -subunits, with the alpha -subunit sharing sequence homology with Kv channel regions S1-S6. Although they are gated by voltage, maxi-KCa (BKCa) channels possess an additional transmembrane (S0) region that renders the NH2-terminus extracellular (237). Interaction of the NH2-terminus with the transmembrane maxi-KCa beta -subunits confers [Ca2+]i sensitivity to the channel. The maxi-KCa COOH-terminus may be substantially longer than that in Kv channels and is the predicted site for protein phosphorylation (237).

Maxi-KCa is also regulated by tyrosine phosphorylation (Table 2). In smooth muscle, STOCs, which reflect the activity of maxi-KCa channels in that cell type, are activated by EGF and inhibited by genistein (70). In neurons, NT3 and NGF activate paxilline-sensitive BKCa channels (76). When the pore-forming alpha -subunit of the BKCa channel, mSlo (the mammalian homologue of slo), is coexpressed with c-Src in HEK 293 cells, the channel undergoes tyrosine phosphorylation (125). Src has no effect on channel gating in the absence of Ca2+, but at free cytosolic Ca2+ levels >4 µM, channel Po is higher at any given voltage when active Src is coexpressed. In contrast, expression of kinase-dead Src prevents tyrosine phosphorylation of the channel and the enhancement in Ca2+ sensitivity (125). The site of regulation appears to be Tyr766 on the COOH-terminus because a Tyr766 to Phe766 mutation prevents phosphorylation of the channel by Src and the subsequent shift in Ca2+ sensitivity (125). These experimental approaches show convincingly that Src is required for tyrosine phosphorylation of the maxi-KCa channel but, as with other studies, it is not certain if the channel is directly phosphorylated by Src or by an intermediate PTK.


    REGULATION OF CA2+ CHANNELS BY PTK
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Voltage-gated Ca2+ channels are composed of alpha 1 (190-250 kDa)-, alpha 2delta (125 kDa)-, and beta  (52-62 kDa)-subunits (47). The alpha 1-subunit forms the voltage-gated Ca2+-selective pore, with some 2,000 amino acids organized in four homologous domains. Each domain contains six transmembrane segments with a membrane reentrant pore loop in each segment (141). Members of the dihydropyridine class of Ca2+ antagonists interact with the alpha 1-subunit (224). beta  and alpha 2delta channel subunits increase functional expression and therefore are likely to play roles in membrane targeting of the channel complex. These subunits also acutely modulate channel function. The beta -subunit is cytoplasmic and contains a highly conserved domain that interacts with the I-II loop of alpha 1. The delta -subunit is an integral membrane protein, whereas alpha 2 is an extracellular glycolsylated protein (106). A gamma -subunit (25 kDa) is found in some tissues, notably skeletal muscle, but its function is uncertain.

At each end of the alpha 1 channel protein are large cytosolic NH2-terminal and COOH-terminal domains that are potential targets for protein phosphorylation. In cardiac and brain isoforms, alpha 1C undergoes posttranslational proteolytic processing, after which a 30- to 50-kDa fragment of the COOH-terminus becomes colocalized with the body (190 kDa) of the alpha 1C- and beta -subunits (63). The COOH-terminus is involved in CaM binding and Ca2+-dependent inactivation. Ser1928 near the COOH-terminus is a major site of PKA-mediated phosphorylation (38). The mechanism of regulation of alpha 1C by PKC is still unclear (106) but requires the NH2-terminus (212). However, when recombinant channels are expressed in HEK 293 cells, phosphorylation of Thr27 and Thr31 by PKC results in inhibition (not activation, as might be expected) of current (141). Because the NH2- and COOH-terminal domains may constitutively serve as partially independent but interacting inhibitory gates (212), it is possible that PKC and other kinases, including PTKs, act by relieving this inhibition.

Several lines of evidence link PTKs to the regulation of the pore-forming subunits of voltage-gated calcium channels, including alpha 1C (132), alpha 1D (222), and alpha 1E (11). Much of this work is summarized in Table 3.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   L-type, N-type, T-type, and HVA Ca2+ channels

At least two isoforms of the L-type Ca2+ channel are regulated by tyrosine phosphorylation. In vascular myocytes, Ca2+ current (alpha 1C-b, Cav1.2b) is reduced by PTK inhibition (127, 260), whereas PTP inhibition increases current (264). PDGF, which stimulates tyrosine phosphorylation of multiple proteins, enhances L-type Ca2+ current (84, 261). A key role for Src kinase in this process is supported by observations that Ca2+ current is 1) increased by intracellular application of constitutively active Src kinase (262), 2) increased by c-Src-activating peptide (263), and 3) inhibited by a monoclonal antibody for c-Src (84). In visceral smooth muscle, PDGF potentiates L-type Ca2+ current and increases tyrosine phosphorylation of alpha 1C (84). Additionally, alpha 1C coimmunoprecipitates with c-Src, and PDGF regulation of current is inhibited by dialysis with antibodies to FAK or Src (84).

Cav1.2b is also regulated by at least three integrins. Whole cell recordings from single arteriolar myocytes show that soluble (nonclustering) ligands of alpha vbeta 3-integrin, such as RGD peptides, inhibit L-type Ca2+ current (271). Interestingly, bound ligands of alpha vbeta 3-integrin, which lead to integrin clustering (146), produce a similar inhibitory effect (271). In contrast, soluble ligands of the laminin receptor, alpha 4beta 1, enhance current (248), whereas only clustered alpha 5beta 1-integrin ligands enhance current (271). Therefore, regulation of this channel in smooth muscle occurs by multiple intracellular pathways downstream from alpha vbeta 3-, alpha 5beta 1-, and alpha 4beta 1-integrins, and at least two of these pathways do not appear to require integrin clustering. As for PDGF-potentiated currents, targeting of FAK or Src in these vascular smooth muscle cells with specific antibodies blocks potentiation of current by alpha 5beta 1-integrin ligands (270). Antibodies to two integrin-associated cytoskeletal protein targets, paxillin and vinculin, also block regulation of L-type Ca2+ current by alpha 5beta 1 ligands. The ability of vinculin and paxillin antibodies to do this is likely due to their interference with the assembly of Src or another PTK on an intracellular scaffold of focal adhesion proteins rather than a direct interaction with the channel. SH2 and SH3 domains in these proteins enable them to associate with PTKs (247). As mentioned above, the COOH-terminus of Cav1.2b contains a proline-rich domain that has been identified as a mediator of membrane association. This region interacts with SH3 domains in Src, Lyn, and Hck tyrosine kinases (63), and its deletion results in increased channel current, suggesting that it is constitutively involved in channel inhibition (258). It is not yet known whether phosphorylation of the alpha 1C COOH-terminus by any of these PTKs alters this inhibitory property.

Depolarization recruits the neuronal L-type Ca2+ channel (Cav1.2c) and results in increased tyrosine phosphorylation of multiple cytoplasmic proteins, including FAK and vinculin. PP1 blocks calcium influx through the channel and reduces phosphorylation of these proteins. Conversely, the phosphatase inhibitor sodium orthovanadate mimics the depolarization effect and recruits the channel (48). In molluscan neurons, NGF acutely enhances high voltage-activated Ca2+ currents (266). Interestingly, the extracellular matrix protein fibronectin produces a similar effect and, in addition, enhances the frequency of action potential firing (W. Wildering, personal communication). Collectively, these observations suggest that Cav1.2c is functionally regulated by tyrosine phosphorylation.

Definitive evidence for regulation of Cav1.2c by the growth factor IGF-1, through Src, was recently presented. In cerebellar granule neurons, alpha 1C is tyrosine phosphorylated in response to IGF-1, resulting in potentiation of L-type Ca2+ current (21, 204). This effect can be duplicated in recombinant alpha 1C-c channels expressed in SH-SY5Y cells. Potentiation occurs primarily as a result of increasing the rate of activation at hyperpolarized potentials and likely reflects altered gating of the alpha 1-subunit. c-Src mediates this response because expression of kinase-dead Src, or application of the soluble Src inhibitor PP2, blocks potentiation of current (16). Kinase assays using lysates from neuroblastoma cells expressing alpha 1C-c show that purified Src kinase phosphorylates Tyr2122 of the alpha 1C-c COOH-terminus. Furthermore, point mutation of Tyr2122 to Phe2122 (but not of a nearby Tyr residue) prevents tyrosine phosphorylation and prevents IGF-1 potentiation of current (16). Because Cav1.2b and Cav1.2c share identical sequences in this region, it is likely that Tyr2122 [rather than other postulated sites (84, 111)] also mediates PDGF potentiation of current in smooth muscle. In addition to this tyrosine phosphorylation site, the intracellular loop of alpha 1C contains two SH3 domains that may be involved in docking of Src. Upstream of Tyr2122 are several amino acid residues that correspond to known sequences of Src substrates, but the various docking, adaptor, or scaffolding proteins that may be required for tyrosine phosphorylation of this channel are not yet known.

T-type Ca2+ current in spermatogenic cells is potentiated by 50% after strong depolarization (e.g., a prepulse to +60 mV) or high-frequency stimulation (11). Unlike voltage-dependent potentiation of current in other Ca2+ channel types, the phenomenon in this tissue is not consistent with a Ca2+- or G protein-mediated mechanism. The same degree of potentiation is produced by PTK inhibitors, whereas PTP inhibitors block prepulse potentiation of current (11). Therefore, tyrosine phosphorylation/dephosphorylation may play a role in acute modulation of this channel.


    REGULATION OF NA+ CHANNELS BY PTKS
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Evidence for the regulation of two major classes of Na+ channels, voltage-gated and epithelial Na+ channels, is summarized in Table 4.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Na+ channels

Voltage-Gated Na+ Channels

Voltage-gated Na+ (VGNa) channels are composed of three subunits: a large pore-forming alpha -subunit and two smaller beta -subunits, beta 1 and beta 2. The alpha -subunit is similar in structure to that of the voltage-gated Ca2+ channel, with four homologous domains, each containing six transmembrane segments. The extracellular domains of the beta -subunits form Ig folds with substantial homology to the neural cell adhesion protein contactin (96) and may therefore play an important role in channel expression and localization. The Na+ channel alpha -subunit is negatively regulated by PKA phosphorylation on Ser573 of the intracellular loop linking domains I and II (28). The alpha -subunit is also regulated by PKC (184, 217). However, only a few studies have examined the possible direct modulation of Na+ channels by phosphorylation on tyrosine residues (Table 4).

In the rat PC12 neuronal cell line, the growth factors NGF, PDGF, EGF, and basic FGF acutely inhibit VGNa (75). Inhibition is achieved through a leftward shift of the Na+ channel inactivation curve, rendering the channel more inactivated at physiological potentials. Inhibition depends on tyrosine kinase activity of the associated growth factor receptors because the receptor PTK inhibitors tyrphostin AG9 and tyrphostin AG879 almost completely reverse this effect. Furthermore, the inhibition of Na+ current by NGF and PDGF is not additive, suggesting a common signaling pathway (but this conclusion may also depend on whether maximal doses of the growth factors were used). Although the specific PTKs involved have not been determined, the Src inhibitor PP1 decreases the response to PDGF in wild-type cells, and PDGF receptors with mutations in their Src-binding domains are less effective in mediating the PDGF response (75).

A recent study of neuronal Na+ channels is one of the few to show a direct association of a PTP with an ion channel. Receptor PTP-beta , a receptor PTP whose mRNA is highly expressed in the brain and kidney (195), interacts with neuronal Na+ channel alpha - and beta 1-subunits through intracellular domains of the proteins (187). In HEK 293 cells, the recombinant alpha -subunit is tyrosine phosphorylated under basal conditions, and the level of phosphorylation increases after treatment with the phosphatase inhibitor sodium pervanadate. Coexpression of alpha -subunits with receptor PTP-beta intracellular phosphatase domains results in an increase in Na+ current due to a rightward shift in voltage-dependent inactivation. Thus interaction of the phosphatase and the channel leads to a reversal of the inhibition by tyrosine phosphorylation (75, 187). The extent to which the actions of endogenous tyrosine kinases and phosphatases differentially modulate VGNa under basal conditions, or in response to hormonal modulation, is not yet known.

Epithelial Na+ Channels

ENaC are important in fluid transport and osmoregulation in epithelia of the airway, colon, kidney, and exocrine glands. ENaCs are composed of three subunits: alpha , beta , and gamma , with uncertain stoichiometry; all three are necessary, however, for maximal channel activity. The putative topology of each subunit is a protein containing two transmembrane domains with intracellular NH2- and COOH-terminal regions (218). ENaCs are not voltage gated in their unphosphorylated state, but gating becomes voltage dependent after phosphorylation by PKA (95). Epithelial Na+ channel activity is also regulated by PKC, arachidonic acid metabolites, and possibly by the cytoskeleton, because the alpha -subunit can bind to spectrin and F-actin (282) and various SH3 domain proteins (139).

Many studies have documented the effects of growth factors on enhancing expression of ion channels, including ENaC, in transporting epithelia. A few of these studies have also noted that PTK inhibitors have apparently acute effects on channels involved in osmoregulation (234). For example, in renal A6 cells, genistein and tyrphostin A23 abolish macroscopic ENaC currents that are elicited by hyposmotic swelling (159). However, this effect is mimicked by an inhibitor of protein translocation, brefeldin A, suggesting that a PTK might not be regulating the channel directly but regulating its insertion into the plasma membrane. It should be noted that interpretation of some of these studies is complicated by the fact that several types of channels interact to determine epithelial water and solute transport, and, in many cases, direct measurements from specific channels have not been made. For example, the RVD of epithelial cells in response to osmotic swelling is sensitive to PTK inhibition (234), but RVD depends on the summed interaction of multiple channels. In addition, these channels functionally interact with transporters, several of which are also known to be sensitive to PTK inhibitors (134, 158).


    REGULATION OF RACC AND CATION CHANNELS BY PTKS
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

In many types of cells, Ca2+-permeable channels can be activated by agonist-receptor interaction, where the receptor protein is distinct from the channel protein. This broad group of channels varies widely in conductance, voltage sensitivity, ion selectivity (e.g., Ca2+ vs. monovalent cation permeability), mechanism of activation, and Ca2+-induced inactivation. Most of these channels have not yet been cloned, so it is difficult to classify them and to define the precise mechanisms by which they are regulated. Barritt (15) has proposed that the commonly used term "receptor-activated Ca2+ channel" (RACC) be used to include non-voltage-gated, Ca2+-permeable channels that are activated by Ca2+ store depletion or second messengers, including Ca2+, Ins(1,4,5)P3, cyclic nucleotides, and G proteins. We will adhere to this convention.

A complete description of the evidence for regulation of RACCs by tyrosine phosphorylation is difficult to compile and categorize, and the reader is referred to recent reviews for more information (15, 53, 167, 240). Table 5 summarizes much of the available data, although it should be noted that, in many cases, electrophysiological measurements were not made and the identity of the specific Ca2+ or cation channel is uncertain.

                              
View this table:
[in this window]
[in a new window]
 
Table 5.   Receptor-activated Ca2+ and cation channels

Store-Operated Channels

A dominant Ca2+ entry pathway in nonexcitable cells is thought to be a plasma membrane Ca2+ channel whose opening is linked to the state of filling of Ca2+ stores. This mechanism has most commonly been termed "store-operated" or "capacitative" Ca2+ influx (182) and is thought to be responsible for refilling endoplasmic reticulum stores and/or the plateau phase of receptor-coupled Ca2+ influx. The characteristics of the channel mediating this influx appear to vary with cell type and with the stimulus that initiates Ca2+ store depletion.

Stimulation of receptor or nonreceptor PTKs is a well-known stimulator of Ca2+ influx in nonexcitable cells (19, 202), and there are numerous reports that PTK inhibitors interfere with capacitative Ca2+ influx (152). The majority of these studies are documented in Table 5.

The first electrophysiological description of a store-operated Ca2+ current was of a small inward current in mast cells, termed Icrac (82). Icrac is activated after store depletion by Ins(1,4,5)P3, EGTA, or SERCA inhibitors, is highly Ca2+ selective, voltage independent, and has an extremely low single channel conductance that can only be estimated from noise analysis (83, 283). Icrac is distinct from other cation-permeable channels, and no specific pharmacological antagonist has been identified (121, 167). Some investigators have distinguished at least two different non-voltage-gated Ca2+ currents in the same cell type (52, 55), including Icrac. In some nonexcitable cells, store-operated Ca2+ currents appear to be less selective for divalent over monovalent cations than Icrac (54, 205, 242) and occasionally display measurable single channel currents (242). Some investigators maintain that these differences represent two distinct types of currents rather than a single family of store-operated currents (167).

At least one report suggests that Icrac may be regulated, perhaps weakly, by PTKs (168). Resolution of this issue is limited by the fact that the molecular nature of the native store-operated channel has not been definitively resolved. The best candidates for a store-operated channel are the Trp family of proteins isolated from Drosophila photoreceptors (150) and from their human homologs (259, 281). Recombinant Trp channels share many, but not all, characteristics of Icrac (149, 167). However, heterologous combinations of Trp isoforms in native cells may account for the unique characteristics of endogenous store-operated currents (93, 176). The mechanism of activation of store-operated channels is highly controversial, but recent evidence links their activation with possible conformational coupling of the Ins(1,4,5)P3 receptor to Trp channels (130, 169). This process requires the cytoskeleton because it is disrupted by cytochalasin or by cortical condensation of actin (169, 190). One Trp isoform has even been shown to contain intrinsic kinase activity (193).

Soluble PTK inhibitors such as genistein, lavendustin A, tyrphostin 47, and MDHC impair capacitative Ca2+ entry (8, 99, 163, 168, 175, 196, 197, 206, 280), whereas vanadate enhances capacitative Ca2+ entry (280). On the basis of these effects, it is proposed that the levels of cytosolic and stored Ca2+ antagonistically control tyrosine phosphorylation of a store-operated channel and/or protein involved in regulation of that channel (246). Indeed, in platelets and fibroblasts, store-operated Ca2+ influx is associated with tyrosine phosphorylation of a 130-kDa protein (116, 196, 246). Unfortunately, few of these studies have used electrophysiological methods to measure store-operated current (except Refs. 168, 175, and 206) and instead infer properties of the underlying channel(s) from measurements of cytosolic [Ca2+]. Thus a common concern with these studies is that Ca2+ influx may have changed with changes in membrane potential due to effects of the inhibitors on other channels. In fact, it is likely that these inhibitors have effects of K+ channels because of the rigorous evidence supporting regulation of K+ channels by tyrosine phosphorylation (Table 2). The observation that in several of these studies some, but not most, soluble PTK inhibitors inhibit capacitative Ca2+ influx (8, 167, 175) raises concern about inhibitor specificity. Alternatively, inhibitors that do not affect store-operated Ca2+ influx or current may simply be acting on PTKs that are not involved the regulation of store-operated channels. Thus a definitive role for tyrosine phosphorylation in the regulation of store-operated Ca2+ channels, including Icrac, remains to be proven.

However, there is substantial evidence that a nonselective cation current in vascular smooth muscle is regulated by tyrosine phosphorylation. In cells isolated from the rabbit portal vein, dialysis with a Src-activating peptide or bath application of insulin activates a 20-pS inward cation current (4). This current has the same characteristics as the current activated by noradrenaline, and the noradrenaline current is inhibited by soluble tyrosine kinase inhibitors. Inhibition of PTPs by sodium orthovanadate also activates the cation current (4). Thus receptor and nonreceptor tyrosine kinases appear to regulate a cation current in this tissue. A recent study provides evidence that this channel may represent a combination of one or more Trp isoforms (93).

CNG Cation Channels

CNG channels play a critical role in vertebrate phototransduction and other cellular processes. For example, light triggers an increase in cytosolic cGMP, which alters channel gating, and this process is regulated by multiple factors, including intracellular Ca2+, CaM, and serine-threonine phosphorylation. The CNG channel protein is heteromeric, consisting of alpha - and beta -subunits (277). Functional channels can be formed by expression of the alpha -subunit alone (147), but the complete role of the beta -subunit remains to be defined.

One type of CNG channel is a voltage-gated cation channel found in bag cell neurons of Aplysia. In this cell, elevations in cAMP trigger a depolarization that leads to repetitive action potential firing. The cation channel is regulated by an endogenous PTP (267), and there is an interesting interaction between serine phosphorylation and tyrosine phosphorylation. The tyrosine phosphorylation state of the channel determines the response of the channel to PKA phosphorylation, i.e., whether PKA will produce an increase or decrease in Po (267).

In expressed CNG channels, PTK inhibitors, but not serine-threonine inhibitors, enhance channel sensitivity to cGMP (148). The alpha -subunit of bRET contains a critical phosphorylation site, Tyr498, on the COOH-terminus that is required for altering cGMP sensitivity (147). Dephosphorylation of this tyrosine residue enhances channel Po. Mutation of this site, Tyr498 to Phe498, but neither of two other COOH-terminal tyrosine residues nor any of several NH2-terminal residues required for CaM regulation, abolishes ~75% of the regulation by cGMP. Moreover, introduction of a tyrosine residue at a comparable site, Phe477 to Tyr477, on the rOLF channel confers partial cGMP sensitivity to the otherwise insensitive native rOLF channel (147). It is interesting that the predicted position of this tyrosine residue is between the ligand-binding site and the rest of the channel protein, i.e., in a strategic position to modulate allosteric gating transitions (147). These results firmly support the idea that the CNG channel is regulated by tyrosine phosphorylation, probably at multiple sites, because mutation of this COOH-terminal tyrosine determines most, but not all, of the cGMP sensitivity. The role of other possible tyrosine phosphorylation sites on this channel and the importance of this mechanism in vivo remain to be determined.


    REGULATION OF CLminus CHANNELS BY PTK
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

Non-ligand-gated Cl- channels have been grouped into four families: 1) Ca2+-activated Cl- channels, 2) voltage-dependent Cl- channels, 3) ClC voltage-gated Cl- channels, and 4) the CFTR channel (58, 244). Many of the first two classes of Cl- channels have not yet been purified and cloned, so identification is based completely on their ion selectivity, pharmacology, current-voltage relationship, and Ca2+ sensitivity. In contrast, much is known about the structure and function of ClC and CFTR channels (100, 110).

ClC channels have membrane topography quite different from voltage-gated cation channels in that they contain 11 transmembrane domains. Yet, like cation channels, both NH2- and COOH-termini are intracellular. ClC-0 channels have two identical, yet independent, conductance levels, leading to the conclusion that there are two pores in each channel (244). ClC-2 and ClC-3 are thought to conduct the swelling-activated Cl- current observed in many cell types. A serine residue (S51) in the ClC-3 NH2-terminus has recently been shown to be a consensus PKC phosphorylation site that determines volume sensitivity (46).

CFTR is a cAMP-regulated Cl- channel that controls salt and water transport across epithelia. It is composed of five membrane-spanning domains and two nucleotide-binding domains linked to a unique, regulatory (R) domain (211). The cytosolic R domain of CFTR contains multiple serine phosphorylation sites, at least five of which are phosphorylated by PKA to stimulate channel activity. PKC phosphorylation may play a facilatory role in PKA phosphorylation of CFTR (211). The NH2-terminus of CFTR binds to the scaffolding protein syntaxin 1A, which appears to exert a tonic inhibitory role on the channel. The COOH-terminus of CFTR binds to several PDZ domain proteins that could potentially link to PTKs and cytoskeletal proteins. It has been proposed that this region of the channel may be involved in formation of a multiprotein signaling complex (110).

At least one study has suggested that CFTR gating is regulated by tyrosine phosphorylation independent of PKA (56). pp60Src was implicated in channel regulation, but a putative tyrosine phosphorylation site was not identified. Furthermore, it is not known if the CFTR NH2- or COOH-termini contain a Src recognition site. It is possible that a PTK only indirectly regulates CFTR function, e.g., by phosphorylating PKC, in a similar manner to the mechanism by which tyrosine phosphorylation of PLC-gamma modulates Cl- current in mesangial cells (132). This would be consistent with the inability of some investigators to detect phosphotyrosines in biochemical assays of CFTR (177).

Specific mechanisms by which other Cl- channels may be regulated by tyrosine phosphorylation are largely unknown (58, 108). As with other channels, a number of studies have shown that Cl- currents are modulated by soluble PTK and PTP inhibitors. This literature is summarized in Table 6.

                              
View this table:
[in this window]
[in a new window]
 
Table 6.   Cl- and CFTR channels

One series of studies stands out. Lepple-Wienhues et al. (118, 119) showed that a native swelling-activated Cl- channel in lymphocytes (presumably a ClC family member) is regulated by p56Lck tyrosine kinase (118). This channel is activated by osmotic swelling and by cAMP, and the process is blocked by genistein or lavendustin A. Furthermore, osmotic swelling produces an increase in p56Lck activity (118). Addition of purified p56Lck activates a Cl- conductance in the absence of swelling. Osmotic activation of the channel is defective in lymphocytes from p56Lck knockout animals but rescued after transfection with cDNA for p56Lck. Although it is not known if the channel is tyrosine phosphorylated by p56Lck or in response to swelling, the collective evidence strongly suggests that Lck regulates this Cl- channel. In a subsequent study, it was shown that osmotic swelling or purified p56Lck can activate the same channel in lymphocytes from patients with cystic fibrosis, suggesting that the channel may partially compensate for defective CFTR (119). Regulation of other ClC channels by PTKs, or even whether other ClC channels contain potential tyrosine phosphorylation sites on their NH2- or COOH-termini, are issues that remain to be resolved.


    THE CHANNEL-PROTEIN KINASE REGULATORY COMPLEX
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

It is becoming clear that regulation of an ion channel by a protein kinase requires the formation of a multiprotein complex. While pore-forming alpha -subunits of many channels bind to auxiliary channel subunits, they also associate with scaffolding proteins that play essential roles in channel localization and activity (124). Scaffolding proteins link signaling enzymes, substrates, and potential effectors (such as channels) into a multiprotein signaling complex that may be anchored to the cytoskeleton. Besides an obvious role in targeting the channel to a particular location on the cell membrane, there are at least three advantages to having an ion channel in a multiprotein complex. First, there is a large increase in the efficiency of the kinetic reaction when an enzyme is localized with its substrate and effector in a microenvironment with restricted diffusion (188). Second, the anchoring of enzyme complexes to some channels may be necessary for the extremely rapid transmission of signals required to regulate some channels (273). Third, compartmentalization may be essential to determining specificity in signal transduction pathways (37).

There appear to be many families of scaffolding and adaptor proteins that could potentially be involved in organizing ion channels into signaling complexes and regulating function by coupling the channels to protein kinases. For serine-threonine kinases, the prominent families are the MAGUK protein, AKAP, and GKAP families (73). Another family of proteins that specifically associates with Kv4.x channels has also recently been described (73). Many scaffolding protein-channel interactions have been identified using yeast two-hybrid screens followed by subsequent immunoprecipitation and GST-fusion protein strategies. In most cases, however, the evidence for an anatomic relationship between the channel and other proteins is stronger than the evidence for a functional relationship. It is beyond the scope of this review to exhaustively discuss the evidence for channel-associated proteins in ion channel regulation (207), but examples from several classes of scaffolding proteins are worth mentioning because PTKs are also associated with some of the same proteins.

MAGUK proteins contain three types of domains that function as sites for specific protein-protein interactions: PDZ, SH3, and GK-like domains. Adjacent GK and SH3 domains, in which the GK domains appear to lack enzymatic activity (180), are defining features of MAGUKs. SH3 domains are proline-rich amino acid sequences found in many signaling and cytoskeleton-associated molecules (170). PDZ domains contain 80-100 amino acids and have been found in many proteins, including 30% of G protein-coupled receptors (186). Although MAGUK proteins are involved in directing protein associations apart from ion channels, there is evidence to support their role in the intracellular localization of several types of channels. Members of this family appear to be essential for proper organization of ion channels at neuronal synapses. For example, colocalization of Shaker family K+ channels with NMDA receptors in neuronal synapses requires PSD-95, SAP97, Chapsyn-110, SAP102, and Dlg, among other scaffolding proteins (208). There are many other examples encompassing both voltage-gated and ligand-gated families of channels (180, 207).

Importantly, the available evidence suggests that the association of scaffolding proteins with channels is part of a general mechanism that not only directs channel localization within a cell but is also essential for regulation of channel function. For example, localization of Shaker Kv1.4c is mediated by the binding of two PDZ domains of PSD-95 to the COOH-terminal cytoplasmic tail of the channel (109). Coexpression of PSD-95 with Kir2.3 in HEK 293 cells suppresses the activity of that channel by >50% (156). SAP97 is required for normal G protein sensitivity of Kir3.2c, an effect mediated through the GK domain of SAP97 (73). Syntaxin, which is abundant in nerve terminals, interacts with voltage-gated Ca2+ channels (18, 209, 210, 269) to shift their voltage dependence of inactivation in a direction that would inhibit presynaptic Ca2+ entry (18). One example that is not specific to the neuronal synapse is syntaxin 1A. That protein interacts with CFTR to tonically inhibit the channel (155). Future studies will likely reveal roles for these or related scaffolding/adaptor proteins in the normal functioning of other channels.

Some channel-associated proteins containing PDZ domains do not belong to the MAGUK protein family. Examples of these include GRIP (44) and Homer (26), which are important for localization of glutamate-gated channels. Most notably, INAD is a Drosophila protein containing five PDZ domains that link together most of the proteins involved directly in phototransduction. This multiprotein complex includes rhodopsin, CaM, the putative store-operated Ca2+ channels Trp and Trpl, and the protein kinases PLC and PKC (88, 273). INAD may serve as a template for understanding how other channels are regulated in a multiprotein complex.

Although the association of other ion channels with PDZ domain proteins and protein kinases is not as firmly established as for INAD, several ion channel-associated PDZ domain proteins do contain catalytic domains (180). Additionally, some of these same proteins contain other signaling domains, e.g., SH3, PH, PTB, PX, and DEP (180), implying that they also associate with other regulatory proteins. As mentioned above, SH3 domains are found in many cytoskeletal and focal adhesion proteins and in most PTKs (247). The alpha 1-subunit of L- and N-type Ca2+ channels has a conserved sequence of proline-rich residues (Prp2039-Pro2194) containing a number of potential SH3-binding motifs (PxxP). This region encompasses part of the channel known to be involved in G protein regulation by beta gamma -subunits (183) and has been shown to bind Src, Lyn, and Hck tyrosine kinases, although the functional significance of these interactions (except for Src, see Ref. 16) is not yet known (63). However, mutant alpha 1C lacking the proline-rich domain exhibits enhanced cation current conduction, consistent with an autoinhibitory role for the COOH-terminus (258). Another sequence at the COOH-terminus of alpha 1B contains a conserved DxxC-COOH motif that allows interaction with PDZ domain proteins such as the scaffolding protein Mint1 through a class III PDZ domain of the latter (137). Furthermore, a proline-rich domain elsewhere in Mint1 interacts with the SH3 domain of CASK, an adaptor protein that contains a calmodulin kinase domain (137). These observations point to the likely possibility that combinations of PDZ, SH3, and other signaling domain sequences may direct protein-protein interactions between ion channels and the kinases that regulate them.

Evidence that scaffolding proteins can mediate kinase-channel interactions is more firmly established for the AKAP family of proteins (66). AKAPs serve to localize both kinases and phosphatases to multiprotein effector complexes that include K+ and Ca2+ channels (41). Evidence for AKAP participation in ion channel regulation has been obtained using both molecular biology and electrophysiology approaches. A general scheme is that a conserved AKAP-anchoring motif directs dimerized PKA subunits to a particular subcellular target (102). For example, forskolin and cAMP potentiate ROMK1 (Kir1.x) current in native renal secretory cells (251). Activity is preserved after patch excision, in which the excised membrane is known to retain channel-associated proteins. However, this potentiation is lost when ROMK1 is expressed in oocytes but restored if AKAP79 is coexpressed with the channel (251). AKAP15/18 is required for PKA potentiation of L-type Ca2+ channels in cardiac (62), skeletal (103), and vascular smooth muscle (60). In skeletal muscle, AKAP15 also aids in localizing L-type Ca2+ channels to transverse tubules (65). AKAPs have also been implicated in the regulation of KCa channels (256) and CFTR (225). AKAP79 associates with both the beta 2-adrenergic receptor and MAGUK proteins, and the latter are coupled to glutamate-gated ion channels. Although it has not yet been proven, AKAP79 has the potential to form part of a scaffold on which PKA and PP2B may dually regulate the coupling of beta 2-adrenergic receptors and glutamate channels (41). Thus AKAPs appear to be capable of assembling signaling complexes by virtue of their associations with other scaffolding proteins. It is possible that AKAPs and INAD represent a general scheme for kinase regulation of channels and that similar families of adaptor proteins associated with other kinases, perhaps PTKs, will soon be identified.


    CONCLUSIONS AND FUTURE DIRECTIONS
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

It should be apparent that there is strong collective evidence to support a role for regulation of ion channels by tyrosine phosphorylation, particularly for ligand-gated channels and voltage-gated cation channels. Our knowledge of the importance of this mechanism for the regulation of other channels will depend largely on the isolation, purification, and cloning of those channels.

On the basis of the evidence described herein, several remaining questions can be identified. What specific PTKs, receptor and nonreceptor, are directly responsible for tyrosine phosphorylation of a particular channel? Can more than one PTK control phosphorylation of a given tyrosine residue on a channel? Are there interactions between tyrosine phosphorylation sites on a channel (5)? Are there interactions between tyrosine phosphorylation sites and serine-threonine phosphorylation sites (267)? What specific endogenous tyrosine phosphatases are involved in ion channel regulation (187)?

Little information is currently available regarding scaffolding and adaptor proteins that might specifically be required for regulation of ion channels by tyrosine phosphorylation. This field lags considerably behind that for serine-threonine phosphorylation systems, but AKAPs, CFTR, and INAD systems may serve as useful models to guide future study.

Finally, a major issue needing to be resolved for virtually every class of ion channel is the physiological role for tyrosine phosphorylation. Many questions remain to be answered. Is there a significant impact of tyrosine phosphorylation on channel function, membrane potential, and/or [Ca2+]i regulation? Does tyrosine phosphorylation produce the same effect on native channels in vivo as it does on recombinant channels in vitro? Is this type of regulation determined by or modified by auxiliary channel subunits (219)? We discussed evidence for physiological relevance, when known, in each of the above sections dealing with specific families of channels. In general, acute regulation of an ion channel by a growth factor (in addition to any effect on channel protein expression) may represent an adaptive mechanism that could be enhanced or unmasked in processes such as tissue repair or remodeling. Moreover, because signaling pathways for nonreceptor tyrosine kinases and growth factors overlap, and in some cases converge on ion channels, it is possible that the adhesion molecules linked to those kinases play a physiological role in the regulation of the channels. This implies that tyrosine phosphorylation may be one mechanism for transduction of mechanical forces through adhesion molecules to ion channels.


    ACKNOWLEDGEMENTS

We thank Judy Davidson for extensive assistance in preparing and proofreading the manuscript.


    FOOTNOTES

This work was supported by National Heart, Lung, and Blood Institute Grants HL-46502 and HL-60180 (to M. J. Davis).

Address for reprint requests and other correspondence: M. J. Davis, Dept. of Medical Physiology, Rm. 346, Reynolds Medical Bldg., Texas A&M Univ., College Station, TX 77843-1114 (E-mail: mjd{at}tamu.edu).


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
RECEPTOR AND NONRECEPTOR...
TYPES OF SUPPORTING EVIDENCE
REGULATION OF LIGAND-GATED...
REGULATION OF K+ CHANNELS...
REGULATION OF CA2+ CHANNELS...
REGULATION OF NA+ CHANNELS...
REGULATION OF RACC AND...
REGULATION OF CL- CHANNELS...
THE CHANNEL-PROTEIN KINASE...
CONCLUSIONS AND FUTURE...
REFERENCES

1.   Abram, CL, and Courtneidge SA. Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254: 1-13, 2000[Web of Science][Medline].

2.   Akiyama, T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, and Fukama Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595, 1987[Abstract/Free Full Text].

3.   Akiyama, T, and Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201: 362-370, 1991[Web of Science][Medline].

4.   Albert, AP, Aromolaran AS, and Large WA. Agents that increase tyrosine phosphorylation activate a non-selective cation current in single rabbit portal vein smooth muscle cells. J Physiol (Lond) 530: 207-217, 2001[Abstract/Free Full Text].

5.   Ali, N, and Agrawal DK. Guanine nucleotide binding regulatory proteins: their characteristics and identification. J Pharmacol Toxicol Methods 32: 187-196, 1994[Web of Science][Medline].

6.   Amico, C, Cupello A, Fossati C, and Robello M. Involvement of phosphatase activities in the run-down of GABAA receptor function in rat cerebellar granule cells in culture. Neuroscience 84: 529-535, 1998[Web of Science][Medline].

7.   Anders, DL, Blevins T, Sutton G, Swope S, Chandler LJ, and Woodward JJ. Fyn tyrosine kinase reduces the ethanol inhibition of recombinant NR1/NR2A but not NR1/NR2B NMDA receptors expressed in HEK 293 cells. J Neurochem 72: 1389-1393, 1999[Web of Science][Medline].

8.   Aptel, HB, Burnay MM, Rossier MF, and Capponi AM. The role of tyrosine kinases in capacitative calcium influx-mediated aldosterone production in bovine adrenal zona glomerulosa cells. J Endocrinol 163: 131-138, 1999[Abstract].

9.   Arcangeli, A, Becchetti A, Mannini A, Mugnai G, De Filippi P, Tarone G, Del Bene MR, Barletta E, Wanke E, and Olivotto M. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 122: 1131-1143, 1993[Abstract/Free Full Text].

10.   Archer, SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, and Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994[Abstract/Free Full Text].

11.   Arnoult, C, Lemos JR, and Florman HM. Voltage-dependent modulation of T-type calcium channels by protein tryosine phosphorylation. EMBO J 16: 1593-1599, 1997[Web of Science][Medline].

12.   Avraham, H, Park SY, Schinkmann K, and Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell Signal 12: 123-133, 2000[Web of Science][Medline].

13.   Babnigg, G, Bowersox SR, and Villereal ML. The role of pp60c-src in the regulation of calcium entry via store-operated calcium channels. J Biol Chem 272: 29434-29437, 1997[Abstract/Free Full Text].

14.   Baldelli, P, Magnelli V, and Carbone E. Selective up-regulation of P- and R-type Ca2+ channels in rat embryo motoneurons by BDNF. Eur J Neurosci 11: 1127-1133, 1999[Web of Science][Medline].

15.   Barritt, GJ. Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem J 337: 153-169, 1999.

16.   Bence-Hanulec, KK, Marshall J, and Blair LA. Potentiation of neuronal L calcium channels by IGF-1 requires phosphorylation of the alpha 1 subunit on a specific tyrosine residue. Neuron 27: 121-131, 2000[Web of Science][Medline].

17.   Berts, A, and Minneman KP. Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2. Eur J Pharmacol 389: 35-40, 2000[Web of Science][Medline].

18.   Bezprozvanny, I, Scheller RH, and Tsien RW. Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378: 623-626, 1995[Medline].

19.   Bhattacharya, S, Ying X, Fu C, Patel R, Kuebler W, Greenberg S, and Bhattacharya J. alpha vbeta 3 Integrin induces tyrosine phosphorylation-dependent Ca2+ influx in pulmonary endothelial cells. Circ Res 86: 456-462, 2000[Abstract/Free Full Text].

20.   Bischof, G, Illek B, Reenstra WW, and Machen TE. Role for tyrosine kinases in carbachol-regulated Ca entry into colonic epithelial cells. Am J Physiol Cell Physiol 268: C154-C161, 1995[Abstract/Free Full Text].

21.   Blair, LA, and Marshall J. IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron 19: 421-429, 1997[Web of Science][Medline].

22.   Boixel, C, Tessier S, Pansard Y, Lang-Lazdunski L, Mercadier JJ, and Hatem SN. Tyrosine kinase and protein kinase C regulate L-type Ca2+ current cooperatively in human atrial myocytes. Am J Physiol Heart Circ Physiol 278: H670-H676, 2000[Abstract/Free Full Text].

23.   Bolotina, VM, Najibi S, Palacino JJ, Pagano PJ, and Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994[Medline].

24.   Bowlby, MR, Fadool DA, Holmes TC, and Levitan IB. Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases. J Gen Physiol 110: 601-610, 1997[Abstract/Free Full Text].

25.   Boxall, AR, and Lancaster B. Tyrosine kinases and synaptic transmission. Eur J Neurosci 10: 2-7, 1998[Web of Science][Medline].

26.   Brakeman, PR, Lanahan AA, O'brien R, Roche K, Barnes CA, Huganir RL, and Worley PF. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386: 284-288, 1997[Medline].

27.   Bryan-Sisneros, A, Sabanov V, Thoroed SM, and Doroshenko P. Dual role of ATP in supporting volume-regulated chloride channels in mouse fibroblasts. Biochim Biophys Acta 1468: 63-72, 2000[Medline].

28.   Cantrell, AR, Smith RD, Goldin AL, Scheuer T, and Catterall WA. Dopaminergic modulation of sodium current in hippocampal neurons via cAMP-dependent phosphorylation of specific sites in the sodium channel alpha subunit. J Neurosci 17: 7330-7338, 1997[Abstract/Free Full Text].

29.   Castel, H, Louiset E, Anouar Y, Le Foll F, Cazin L, and Vaudry H. Regulation of GABAA receptor by protein tyrosine kinases in frog pituitary melanotrophs. J Neuroendocrinol 12: 41-52, 2000[Web of Science][Medline].

30.   Cataldi, M, Taglialatela M, Guerriero S, Amoroso S, Lombardi G, Di Renzo G, and Annunziato L. Protein-tyrosine kinases activate while protein-tyrosine phosophatases inhibit L-type calcium channel activity in pituitary GH3 cells. J Biol Chem 271: 9441-9446, 1996[Abstract/Free Full Text].

31.   Chapron, Y, Cochet C, Crouzy S, Jullien T, Keramidas M, and Verdetti J. Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels. Biochem Biophys Res Commun 158: 527-533, 1989[Web of Science][Medline].

32.   Chauhan-Patel, R, and Spruce AE. Differential regulation of potassium currents by FGF-1 and FGF-2 in embryonic Xenopus laevis myocytes. J Physiol (Lond) 512: 109-118, 1998[Abstract/Free Full Text].

33.   Chiang, CE, Chen SA, Chang MS, Lin CI, and Luk HN. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochem Biophys Res Commun 223: 598-603, 1996[Web of Science][Medline].

34.   Chik, CL, Li B, Karpinski E, and Ho AK. Insulin and insulin-like growth factor-I inhibit the L-type calcium channel current in rat pinealocytes. Endocrinology 138: 2033-2042, 1997[Abstract/Free Full Text].

35.   Colledge, M, and Froehner SC. Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding. J Neurosci 17: 5038-5045, 1997[Abstract/Free Full Text].

36.   Colledge, M, and Froehner SC. Signals mediating ion channel clustering at the neuromuscular junction. Curr Opin Neurobiol 8: 357-363, 1998[Web of Science][Medline].

37.   Colledge, M, and Scott JD. AKAPs: from structure to function. Trends Cell Biol 9: 216-221, 1999[Web of Science][Medline].

38.   De Jongh, KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, and Catterall WA. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase. Biochemistry 35: 10392-10402, 1996[Medline].

39.   Delbono, O, Renganathan M, and Messi ML. Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor. J Neurosci 17: 6918-6928, 1997[Abstract/Free Full Text].

40.   Disalvo, J, Pfitzer G, and Semenchuck LA. Protein tyrosine phosphorylation, cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 72: 1434-1439, 1994[Web of Science][Medline].

41.   Dodge, K, and Scott JD. AKAP79 and the evolution of the AKAP model. FEBS Lett 476: 58-61, 2000[Web of Science][Medline].

42.   Dolly, JO, and Parcej DN. Molecular properties of voltage-gated K+ channels. J Bioenerg Biomembr 28: 231-253, 1996[Web of Science][Medline].

43.   Dolly, JO, Rettig J, Scott VE, Parcej DN, Wittkat R, Sewing S, and Pongs O. Oligomeric and subunit structures of neuronal voltage-sensitive K+ channels. Biochem Soc Trans 22: 473-478, 1994[Web of Science][Medline].

44.   Dong, H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, and Huganir RL. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386: 279-284, 1997[Medline].

45.   Doroshenko, P. Pervanadate inhibits volume-sensitive chloride current in bovine chromaffin cells. Pflügers Arch 435: 303-309, 1998[Web of Science][Medline].

46.   Duan, D, Cowley S, Horowitz B, and Hume JR. A serine residue in ClC-3 links phosphorylation-dephosphorylation to chloride channel regulation by cell volume. J Gen Physiol 113: 57-70, 1999[Abstract/Free Full Text].

47.   Ertel, EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, Tsien RW, and Catterall WA. Nomenclature of voltage-gated calcium channels. Neuron 25: 533-535, 2000[Web of Science][Medline].

48.   Evans, GJO, and Pocock JM. Modulation of neurotransmitter release by dihydropyridine-sensitive calcium channels involves tyrosine phosphorylation. Eur J Neurosci 11: 279-292, 1999[Web of Science][Medline].

49.   Fadool, DA, Holmes TC, Berman K, Dagan D, and Levitan IB. Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel. J Neurophysiol 78: 1563-1573, 1997[Abstract/Free Full Text].

50.   Fadool, DA, and Levitan IB. Modulation of olfactory bulb neuron potassium current by tyrosine phosphorylation. J Neurosci 18: 6126-6137, 1998[Abstract/Free Full Text].

51.   Fantl, WJ, Johnson DE, and Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993[Web of Science][Medline].

52.   Fasolato, C, Hoth M, Matthews G, and Penner R. Ca2+ and Mn2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc Natl Acad Sci USA 90: 3068-3072, 1993[Abstract/Free Full Text].

53.   Fasolato, C, Innocenti B, and Pozzan T. Receptor-activated Ca2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 15: 77-83, 1994[Medline].

54.   Fasolato, C, and Nilius B. Store depletion triggers the calcium release-activated calcium current (ICRAC) in macrovascular endothelial cells: a comparison with Jurkat and embryonic kidney cell lines. Pflügers Arch 436: 69-74, 1998[Web of Science][Medline].

55.   Fernando, KC, and Barritt GJ. Characterisation of the divalent cation channels of the hepatocyte plasma membrane receptor-activated Ca2+ inflow system using lanthanide ions. Biochim Biophys Acta 1268: 97-106, 1995[Medline].

56.   Fischer, H, and Machen TE. The tyrosine kinase p60c-src regulates the fast gate of the cystic fibrosis transmembrane conductance regulator chloride channel. Biophys J 71: 3073-3082, 1996[Web of Science][Medline].

57.   Fitzgerald, EM, and Dolphin AC. Regulation of rat neuronal voltage-dependent calcium channels by endogenous p21-ras. Eur J Neurosci 9: 1252-1261, 1997[Web of Science][Medline].

58.   Frings, S, Reuter D, and Kleene SJ. Neuronal Ca2+-activated Cl- channels-homing in on an elusive channel species. Prog Neurobiol 60: 247-289, 2000[Web of Science][Medline].

59.   Fuhrer, C, and Hall ZW. Functional interaction of Src family kinases with the acetylcholine receptor in C2 myotubes. J Biol Chem 271: 32474-32481, 1996[Abstract/Free Full Text].

60.   Fukao, M, Mason HS, Britton FC, Kenyon JL, Horowitz B, and Keef KD. Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072. J Biol Chem 274: 10927-10935, 1999[Abstract/Free Full Text].

61.   Furukawa, K, Onodera H, Kogure K, and Akaike N. Alterations of Ca2+ currents and their sensitivities to Ca2+ antagonists during application and after deprivation of nerve growth factor. Neurosci Lett 161: 13-16, 1993[Web of Science][Medline].

62.   Gao, T, Yatani A, Dell'acqua ML, Sako H, Green SA, Dascal N, Scott JD, and Hosey MM. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19: 185-196, 1997[Web of Science][Medline].

63.   Gerhardstein, BL, Gao T, Bunemann M, Puri TS, Adair A, Ma H, and Hosey MM. Proteolytic processing of the C terminus of the alpha (1C) subunit of L-type calcium channels and the role of a proline-rich domain in membrane tethering of proteolytic fragments. J Biol Chem 275: 8556-8563, 2000[Abstract/Free Full Text].

64.   Gould, EM, Rembold CM, and Murphy RA. Genistein, a tyrosine kinase inhibitor, reduces Ca2+ mobilization in swine carotid media. Am J Physiol Cell Physiol 268: C1425-C1429, 1995[Abstract/Free Full Text].

65.   Gray, PC, Johnson BD, Westenbroek RE, Hays LG, Yates JR, III, Scheuer T, Catterall WA, and Murphy BJ. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron 20: 1017-1026, 1998[Web of Science][Medline].

66.   Gray, PC, Scott JD, and Catterall WA. Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins. Curr Opin Neurobiol 8: 330-334, 1998[Web of Science][Medline].

67.   Gronroos, E, Schippert A, Engstrom M, and Sjolander A. The regulation of leukotriene D4-induced calcium influx in human epithelial cells involves protein tyrosine phosphorylation. Cell Calcium 17: 177-186, 1995[Web of Science][Medline].

68.   Gulbins, E, Szabo I, Baltzer K, and Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA 94: 7661-7666, 1997[Abstract/Free Full Text].

69.   Harder, KW, Moller NP, Peacock JW, and Jirik FR. Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. J Biol Chem 273: 31890-31900, 1998[Abstract/Free Full Text].

70.   Hatakeyama, N, Mukhopadhyay D, Goyal RK, and Akbarali HI. Tryosine kinase-dependent modulation of calcium entry in rabbit colonic muscularis mucosae. Am J Physiol Cell Physiol 270: C1780-C1789, 1996[Abstract/Free Full Text].

71.   Hayashi, T, Umemori H, Mishina M, and Yamamoto T. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 397: 72-76, 1999[Medline].

72.   Herzig, S, and Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 80: 173-210, 2000[Abstract/Free Full Text].

73.   Hibino, H, Inanobe A, Tanemoto M, Fujita A, Doi K, Kubo T, Hata Y, Takai Y, and Kurachi Y. Anchoring proteins confer G protein sensitivity to an inward-rectifier K+ channel through the GK domain. EMBO J 19: 78-83, 2000[Web of Science][Medline].

74.   Hida, H, Takeda M, and Soliven B. Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes. J Neurosci 18: 8712-8719, 1998[Abstract/Free Full Text].

75.   Hilborn, MD, Vaillancourt RR, and Rane SG. Growth factor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway. J Neurosci 18: 590-600, 1998[Abstract/Free Full Text].

76.   Holm, NR, Christophersen P, Olesen SP, and Gammeltoft S. Activation of calcium-dependent potassium channels in mouse brain neurons by neurotrophin-3 and nerve growth factor. Proc Natl Acad Sci USA 94: 1002-1006, 1997[Abstract/Free Full Text].

77.   Holmes, TC, Berman K, Swartz JE, Dagan D, and Levitan IB. Expression of voltage-gated potassium channels decreases cellular protein tyrosine phosphorylation. J Neurosci 17: 8964-8974, 1997[Abstract/Free Full Text].

78.   Holmes, TC, Fadool DA, and Levitan IB. Tyrosine phosphorylation of the Kv1.3 potassium channel. J Neurosci 16: 1581-1590, 1996[Abstract/Free Full Text].

79.   Holmes, TC, Fadool DA, Ren RB, and Levitan IB. Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain. Science 274: 2089-2091, 1996[Abstract/Free Full Text].

80.   Hool, LC, Middleton LM, and Harvey RD. Genistein increases the sensitivity of cardiac ion channels to beta -adrenergic receptor stimulation. Circ Res 83: 33-42, 1998[Abstract/Free Full Text].

81.   Hopfield, JF, Tank DW, Greengard P, and Huganir RL. Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation. Nature 336: 677-680, 1988[Medline].

82.   Hoth, M, and Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353-356, 1992[Medline].

83.   Hoth, M, and Penner R. Calcium release-activated calcium current in rat mast cells. J Physiol (Lond) 465: 359-386, 1993[Abstract/Free Full Text].

84.   Hu, XQ, Singh N, Mukhopadhyay D, and Akbarali HI. Modulation of voltage-dependent Ca2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 273: 5337-5342, 1998[Abstract/Free Full Text].

85.   Huang, R, and Dillon GH. Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor. Neuropharmacology 39: 2195-2204, 2000[Web of Science][Medline].

86.   Huang, RQ, Fang MJ, and Dillon GH. The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors. Brain Res Mol Brain Res 67: 177-183, 1999[Medline].

87.   Huang, XY, Morielli AD, and Peralta EG. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell 75: 1145-1156, 1993[Web of Science][Medline].

88.   Huber, A, Sander P, Bahner M, and Paulsen R. The TRP Ca2+ channel assembled in a signaling complex by the PDZ domain protein INAD is phosphorylated through the interaction with protein kinase C (ePKC). FEBS Lett 425: 317-322, 1998[Web of Science][Medline].

89.   Huganir, RL. Regulation of the nicotinic acetylcholine receptor by serine and tyrosine protein kinases. Adv Exp Med Biol 287: 279-294, 1991[Medline].

90.   Huganir, RL, Miles K, and Greengard P. Phosphorylation of the nicotinic acetylcholine receptor by an endogenous tyrosine-specific protein kinase. Proc Natl Acad Sci USA 81: 6968-6972, 1984[Abstract/Free Full Text].

91.   Hunter, T, and Cooper JA. Protein-tyrosine kinases. Annu Rev Biochem 54: 897-930, 1985[Web of Science][Medline].

92.   Illek, B, Fischer H, and Machen TE. Alternate stimulation of apical CFTR by genistein in epithelia. Am J Physiol Cell Physiol 270: C265-C275, 1996[Abstract/Free Full Text].

93.   Inoue, R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, and Mori Y. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha 1-adrenoceptor-activated Ca2+-permeable cation channel. Circ Res 88: 325-332, 2001[Abstract/Free Full Text].

94.   Inoue, R, Waniishi Y, Yamada K, and Ito Y. A possible role of tyrosine kinases in the regulation of muscarinic receptor-activated cation channels in guinea pig ileum. Biochem Biophys Res Commun 203: 1392-1397, 1994[Web of Science][Medline].

95.   Ismailov, II, and Benos DJ. Effects of phosphorylation on ion channel function. Kidney Int 48: 1167-1179, 1995[Web of Science][Medline].

96.   Isom, LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, Scheuer T, and Catterall WA. Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83: 433-442, 1995[Web of Science][Medline].

97.   Jan, LY, and Jan YN. Cloned potassium channels from eukaryotes and prokaryotes. Annu Rev Neurosci 20: 91-123, 1997[Web of Science][Medline].

98.   Jassar, BS, Ostashewski PM, and Jhamandas JH. GABAA receptor modulation by protein tyrosine kinase in the rat diagonal band of Broca. Brain Res 775: 127-133, 1997[Web of Science][Medline].

99.   Jenner, S, Farndale RW, and Sage SO. The effect of calcium-store depletion and refilling with various bivalent cations on tyrosine phosphorylation and Mn2+ entry in fura-2-loaded human platelets. Biochem J 303: 337-339, 1994.

100.   Jentsch, TJ, Friedrich T, Schriever A, and Yamada H. The CLC chloride channel family. Pflügers Arch 437: 783-795, 1999[Web of Science][Medline].

101.   Jing, J, Peretz T, Singer-Lahat D, Chikvashvili D, Thornhill WB, and Lotan I. Inactivation of a voltage-dependent K+ channel by beta  subunit. Modulation by a phosphorylation-dependent interaction between the distal C terminus of alpha  subunit and cytoskeleton. J Biol Chem 272: 14021-14024, 1997[Abstract/Free Full Text].

102.   Johnson, BD. The company they keep: ion channels and their intracellular regulatory partners. Adv Second Messenger Phosphoprotein Res 33: 203-228, 1999[Web of Science][Medline].

103.   Johnson, BD, Scheuer T, and Catterall WA. Voltage-dependent potentiation of L-type Ca2+ channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 11492-11496, 1994[Abstract/Free Full Text].

104.   Jonas, EA, and Kaczmarek LK. Regulation of potassium channels by protein kinases. Curr Opin Neurobiol 6: 318-323, 1996[Web of Science][Medline].

105.   Jonas, EA, Knox RJ, Kaczmarek LK, Schwartz JH, and Solomon DH. Insulin receptor in Aplysia neurons: characterization, molecular cloning, and modulation of ion currents. J Neurosci 16: 1645-1658, 1996[Abstract/Free Full Text].

106.   Kamp, TJ, and Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102, 2000[Abstract/Free Full Text].

107.   Katsube, Y, Yokoshiki H, Nguyen L, Yamamoto M, and Sperelakis N. Inhibition of Ca2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein. Eur J Pharmacol 345: 309-314, 1998[Web of Science][Medline].

108.   Kidd, JF, and Thorn P. Intracellular Ca2+ and Cl- channel activation in secretory cells. Annu Rev Physiol 62: 493-513, 2000[Web of Science][Medline].

109.   Kim, E, Niethammer M, Rothschild A, Jan YN, and Sheng M. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378: 85-88, 1995[Medline].

110.   Kirk, KL. New paradigms of CFTR chloride channel regulation. Cell Mol Life Sci 57: 623-634, 2000[Web of Science][Medline].

111.   Koch, WJ, Ellinor PT, and Schwartz A. cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms. J Biol Chem 265: 17786-17791, 1990[Abstract/Free Full Text].

112.   Köhr, G, and Seeburg PH. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J Physiol (Lond) 492: 445-452, 1996[Abstract/Free Full Text].

113.   Kusaka, M, and Sperelakis N. Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells. Biochim Biophys Acta 1240: 196-200, 1995[Medline].

114.   Kusaka, M, and Sperelakis N. Genistein inhibition of fast Na+ current in uterine leiomyosarcoma cells is independent of tyrosine kinase inhibition. Biochim Biophys Acta 1278: 1-4, 1996[Medline].

115.   Lau, LF, and Huganir RL. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 270: 20036-20041, 1995[Abstract/Free Full Text].

116.   Lee, KM, Toscas K, and Villereal ML. Inhibition of bradykinin- and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors. J Biol Chem 268: 9945-9948, 1993[Abstract/Free Full Text].

117.   Lemmon, MA, and Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 19: 459-463, 1994[Web of Science][Medline].

118.   Lepple-Wienhues, A, Szabó I, Laun T, Kaba NK, Gulbins E, and Lang F. The tyrosine kinase p56lck mediates activation of swelling-induced chloride channels in lymphocytes. J Cell Biol 141: 281-286, 1998[Abstract/Free Full Text].

119.   Lepple-Wienhues, A, Szabo I, Wieland U, Heil L, Gulbins E, and Lang F. Tyrosine kinases open lymphocyte chloride channels. Cell Physiol Biochem 10: 307-312, 2000[Web of Science][Medline].

120.   Lesser, SS, and Lo DC. Regulation of voltage-gated ion channels by NGF and ciliary neurotrophic factor in SK-N-SH neuroblastoma cells. J Neurosci 15: 253-261, 1995[Abstract].

121.   Leung, YM, and Kwan CY. Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers. Jpn J Pharmacol 81: 253-258, 1999[Medline].

122.   Lev, S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, and Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions. Nature 376: 737-745, 1995[Medline].

123.   Levitan, IB. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol 56: 193-212, 1994[Web of Science][Medline].

124.   Levitan, IB. Modulation of ion channels by protein phosphorylation-how the brain works. Adv Second Messenger Phosphoprotein Res 33: 3-22, 1999[Web of Science][Medline].

125.   Ling, S, Woronuk G, Sy L, Lev S, and Braun AP. Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of Src tyrosine kinase. J Biol Chem 275: 30683-30689, 2000[Abstract/Free Full Text].

126.   Liu, H, Li K, and Sperelakis N. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can J Physiol Pharmacol 75: 1058-1062, 1997[Web of Science][Medline].

127.   Liu, H, and Sperelakis N. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein. Can J Physiol Pharmacol 75: 1063-1068, 1997[Web of Science][Medline].

128.   Ma, H, Matsunaga H, Li B, Marrero MB, and Ling BN. Regulation of PDGF-beta receptor-operated Ca2+ channels by phospholipase Cgamma -1 in glomerular mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 271: F994-F1003, 1996[Abstract/Free Full Text].

129.   Ma, H, Matsunaga H, Li B, Schieffer B, Marrero MB, and Ling BN. Ca2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells. J Clin Invest 97: 2332-2341, 1996[Web of Science][Medline].

130.   Ma, HT, Patterson RL, Van Rossum DB, Birnbaumer L, Mikoshiba K, and Gill DL. Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels. Science 287: 1647-1651, 2000[Abstract/Free Full Text].

131.   Macfarlane, SN, and Sontheimer H. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes. J Neurosci 20: 5245-5253, 2000[Abstract/Free Full Text].

132.   Marrero, MB, Schieffer B, Bernstein KE, and Ling BN. Angiotensin II-induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells. Clin Exp Pharmacol Physiol 23: 83-88, 1996[Web of Science][Medline].

133.   Marrero, MB, Schieffer B, Ma H, Bernstein KE, and Ling BN. ANG II-induced tyrosine phosphorylation stimulates phospholipase C-gamma 1 and Cl- channels in mesangial cells. Am J Physiol Cell Physiol 270: C1834-C1842, 1996[Abstract/Free Full Text].

134.   Marunaka, Y, Niisato N, O'Brodovich H, Post M, and Tanswell AK. Roles of Ca2+ and protein tyrosine kinase in insulin action on cell volume via Na+ and K+ channels and Na+/K+/2Cl- cotransporter in fetal rat alveolar type II pneumocyte. J Membr Biol 168: 91-101, 1999[Web of Science][Medline].

135.   Masumoto, N, Nakayama K, Oyabe A, Uchino M, Ishii K, Obara K, and Tanabe Y. Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A. Eur J Pharmacol 330: 55-63, 1997[Web of Science][Medline].

136.   Matsumoto, PS, Ohara A, Duchatelle P, and Eaton DC. Tyrosine kinase regulates epithelial sodium transport in A6 cells. Am J Physiol Cell Physiol 264: C246-C250, 1993[Abstract/Free Full Text].

137.   Maximov, A, Sudhof TC, and Bezprozvanny I. Association of neuronal calcium channels with modular adaptor proteins. J Biol Chem 274: 24453-24456, 1999[Abstract/Free Full Text].

138.   Mays, DJ, Foose JM, Philipson LH, and Tamkun MM. Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue. J Clin Invest 96: 282-292, 1995.

139.   Mcdonald, FJ, and Welsh MJ. Binding of the proline-rich region of the epithelial Na+ channel to SH3 domains and its association with specific cellular proteins. Biochem J 312: 491-497, 1995.

140.   Mcdonald, TF, Pelzer S, Trautwein W, and Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 74: 365-507, 1994[Free Full Text].

141.   McHugh, D, Sharp EM, Scheuer T, and Catterall WA. Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proc Natl Acad Sci USA 97: 12334-12338, 2000[Abstract/Free Full Text].

142.   Mergler, S, Steinhausen K, Wiederholt M, and Strauss O. Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiologic effect in retinal degeneration. FASEB J 12: 1125-1134, 1998[Abstract/Free Full Text].

143.   Meucci, O, Scorziello A, Avallone A, Florio T, D'alto V, Fattore M, and Schettini G. alpha 1B, But not alpha 1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores, in PC Cl3 rat thyroid cell line. Biochem Biophys Res Commun 209: 630-638, 1995[Web of Science][Medline].

144.   Meza, U, Bannister R, Melliti K, and Adams B. Biphasic, opposing modulation of cloned neuronal alpha 1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors. J Neurosci 19: 6806-6817, 1999[Abstract/Free Full Text].

145.   Minami, K, Fukuzawa K, and Inoue I. Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase. Pflügers Arch 426: 254-257, 1994[Web of Science][Medline].

146.   Miyamoto, S, Akiyama SK, and Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267: 883-885, 1995[Abstract/Free Full Text].

147.   Molokanova, E, Maddox F, Luetje CW, and Kramer RH. Activity-dependent modulation of rod photoreceptor cyclic nucleotide-gated channels mediated by phosphorylation of a specific tyrosine residue. J Neurosci 19: 4786-4795, 1999[Abstract/Free Full Text].

148.   Molokanova, E, Trivedi B, Savchenko A, and Kramer RH. Modulation of rod photoreceptor cyclic nucleotide-gated channels by tyrosine phosphorylation. J Neurosci 17: 9068-9076, 1997[Abstract/Free Full Text].

149.   Montell, C. Visual transduction in Drosophila. Annu Rev Cell Dev Biol 15: 231-268, 1999[Web of Science][Medline].

150.   Montell, C, and Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 2: 1313-1323, 1989[Web of Science][Medline].

151.   Moon, IS, Apperson ML, and Kennedy MB. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc Natl Acad Sci USA 91: 3954-3958, 1994[Abstract/Free Full Text].

152.   Mori, Y, Okada T, and Shimizu S. Receptor-activated Ca2+ influx: capacitative Ca2+ entry and TRP proteins. Nippon Yakurigaku Zasshi 114: 149-160, 1999[Medline].

153.   Morikawa, H, Fukuda K, Mima H, Shoda T, Kato S, and Mori K. Tyrosine kinase inhibitors suppress N-type and T-type Ca2+ channel currents in NG108-15 cells. Pflügers Arch 436: 127-132, 1998[Web of Science][Medline].

154.   Moss, SJ, Gorrie GH, Amato A, and Smart TG. Modulation of GABAA receptors by tyrosine phosphorylation. Nature 377: 344-348, 1995[Medline].

155.   Naren, AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, Benos DJ, Quick MW, and Kirk KL. Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 390: 302-305, 1997[Medline].

156.   Nehring, RB, Wischmeyer E, Doring F, Veh RW, Sheng M, and Karschin A. Neuronal inwardly rectifying K+ channels differentially couple to PDZ proteins of the PSD-95/SAP90 family. J Neurosci 20: 156-162, 2000[Abstract/Free Full Text].

157.   Nelson, MT, and Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268: C799-C822, 1995[Abstract/Free Full Text].

158.   Niisato, N, Ito Y, and Marunaka Y. Activation of Cl- channel and Na+/K+/2Cl- cotransporter in renal epithelial A6 cells by flavonoids: genistein, daidzein, and apigenin. Biochem Biophys Res Commun 254: 368-371, 1999[Web of Science][Medline].

159.   Niisato, N, Van Driessche W, Liu M, and Marunaka Y. Involvement of protein tyrosine kinase in osmoregulation of Na+ transport and membrane capacitance in renal A6 cells. J Membr Biol 175: 63-77, 2000[Web of Science][Medline].

160.   Niklinska, BB, Yamada H, O'Shea JJ, June CH, and Ashwell JD. Tyrosine kinase-regulated and inositol phosphate-independent Ca2+ elevation and mobilization in T cells. J Biol Chem 267: 7154-7159, 1992[Abstract/Free Full Text].

161.   Nishio, M, Habuchi Y, Tanaka H, Morikawa J, Okanoue T, and Kashima K. Tyrosine kinase-dependent modulation by interferon-alpha of the ATP-sensitive K+ current in rabbit ventricular myocytes. FEBS Lett 445: 87-91, 1999[Web of Science][Medline].

162.   Ogura, T, Shuba LM, and Mcdonald TF. L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 276: H1724-H1733, 1999[Abstract/Free Full Text].

163.   Ohta, T, Yasuda W, Hasegawa A, Ito S, and Nakazato Y. Effects of inhibitors for tyrosine kinase and non-selective cation channel on capacitative Ca2+ entry in rat ileal smooth muscle. Eur J Pharmacol 387: 211-220, 2000[Web of Science][Medline].

164.   Okada, M, and Nakagawa H. A protein tyrosine kinase involved in regulation of pp60c-src function. J Biol Chem 264: 20886-20893, 1989[Abstract/Free Full Text].

165.   Osol, G, Laher I, and Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol Heart Circ Physiol 265: H415-H420, 1993[Abstract/Free Full Text].

166.   Paillart, C, Carlier E, Guedin D, Dargent B, and Couraud F. Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor. J Pharmacol Exp Ther 280: 521-526, 1997[Abstract/Free Full Text].

167.   Parekh, AB, and Penner R. Store depletion and calcium influx. Physiol Rev 77: 901-930, 1997[Abstract/Free Full Text].

168.   Parekh, AB, Terlau H, and Stühmer W. Depletion of InsP3 stores activates a Ca2+ and K+ current by means of a phosphatase and a diffusible messenger. Nature 364: 814-818, 1993[Medline].

169.   Patterson, RL, Van Rossum DB, and Gill DL. Store-operated Ca2+ entry: evidence for a secretion-like coupling model. Cell 98: 487-499, 1999[Web of Science][Medline].

170.   Pawson, T, and Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080, 1997[Abstract/Free Full Text].

171.   Pearson, RB, and Kemp BE. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 200: 62-81, 1991[Web of Science][Medline].

172.   Peppelenbosch, MP, Tertoolen LG, and De Laat SW. Epidermal growth factor-activated calcium and potassium channels. J Biol Chem 266: 19938-19944, 1991[Abstract/Free Full Text].

173.   Peretz, A, Sobko A, and Attali B. Tyrosine kinases modulate K+ channel gating in mouse Schwann cells. J Physiol (Lond) 519: 373-384, 1999[Abstract/Free Full Text].

174.   Petrone, A, and Sap J. Emerging issues in receptor protein tyrosine phosphatase function: lifting fog or simply shifting? J Cell Sci 113: 2345-2354, 2000[Abstract].

175.   Pfeiffer, F, Schmid A, and Schulz I. Capacitative Ca2+ influx and a Ca2+ dependent nonselective cation pathway are discriminated by genistein in mouse pancreatic acinar cells. Pflügers Arch 430: 916-922, 1995[Web of Science][Medline].

176.   Philipp, S, Trost C, Warnat J, Rautmann J, Himmerkus N, Schroth G, Kretz O, Nastainczyk W, Cavalie A, Hoth M, and Flockerzi V. TRP4 (CCE1) protein is part of native calcium release-activated Ca2+-like channels in adrenal cells. J Biol Chem 275: 23965-23972, 2000[Abstract/Free Full Text].

177.   Picciotto, MR, Cohn JA, Bertuzzi G, Greengard P, and Nairn AC. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 267: 12742-12752, 1992[Abstract/Free Full Text].

178.   Pollock, JD, Krempin M, and Rudy B. Differential effects of NGF, FGF, EGF, cAMP, and dexamethasone on neurite outgrowth and sodium channel expression in PC12 cells. J Neurosci 10: 2626-2637, 1990[Abstract].

179.   Polte, TR, and Hanks SK. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130Cas) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J Biol Chem 272: 5501-5509, 1997[Abstract/Free Full Text].

180.   Ponting, CP, Phillips C, Davies KE, and Blake DJ. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 19: 469-479, 1997[Web of Science][Medline].

181.   Prevarskaya, NB, Skryma RN, Vacher P, Daniel N, Djiane J, and Dufy B. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. J Biol Chem 270: 24292-24299, 1995[Abstract/Free Full Text].

182.   Putney, JW, Jr. A model for receptor-regulated calcium entry. Cell Calcium 7: 1-12, 1986[Web of Science][Medline].

183.   Qin, N, Platano D, Olcese R, Stefani E, and Birnbaumer L. Direct interaction of Gbeta gamma with a C-terminal Gbeta gamma -binding domain of the Ca2+ channel alpha 1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci USA 94: 8866-8871, 1997[Abstract/Free Full Text].

184.   Qu, Y, Rogers J, Tanada T, Scheuer T, and Catterall WA. Modulation of cardiac Na+ channels expressed in a mammalian cell line and in ventricular myocytes by protein kinase C. Proc Natl Acad Sci USA 91: 3289-3293, 1994[Abstract/Free Full Text].

185.   Rane, SG, and Pollock JD. Fibroblast growth factor-induced increases in calcium currents in the PC12 pheochromocytoma cell line are tyrosine phosphorylation dependent. J Neurosci Res 38: 590-598, 1994[Web of Science][Medline].

186.   Ranganathan, R, and Ross EM. PDZ domain proteins: scaffolds for signaling complexes. Curr Biol 7: R770-R773, 1997[Web of Science][Medline].

187.   Ratcliffe, CF, Qu Y, McCormick KA, Tibbs VC, Dixon JE, Scheuer T, and Catterall WA. A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta . Nature Neurosci 3: 437-444, 2000[Web of Science][Medline].

188.   Ricard, J, Giudici-Orticoni MT, and Gontero B. The modulation of enzyme reaction rates within multi-enzyme complexes. I. Statistical thermodynamics of information transfer through multi-enzyme complexes. Eur J Biochem 226: 993-998, 1994[Web of Science][Medline].

189.   Rogalski, SL, Appleyard SM, Pattillo A, Terman GW, and Chavkin C. TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel. J Biol Chem 275: 25082-25088, 2000[Abstract/Free Full Text].

190.   Rosado, JA, Jenner S, and Sage SO. A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Evidence for conformational coupling. J Biol Chem 275: 7527-7533, 2000[Abstract/Free Full Text].

191.   Rosenblum, K, Dudai Y, and Richter-Levin G. Long-term potentiation increases tyrosine phosphorylation of the N- methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc Natl Acad Sci USA 93: 10457-10460, 1996[Abstract/Free Full Text].

192.   Rostas, JA, Brent VA, Voss K, Errington ML, Bliss TV, and Gurd JW. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci USA 93: 10452-10456, 1996[Abstract/Free Full Text].

193.   Runnels, LW, Yue L, and Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001[Abstract/Free Full Text].

194.   Ruppersberg, JP. Intracellular regulation of inward rectifier K+ channels. Pflügers Arch 441: 1-11, 2000[Web of Science][Medline].

195.   Sap, J, D'eustachio P, Givol D, and Schlessinger J. Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Natl Acad Sci USA 87: 6112-6116, 1990[Abstract/Free Full Text].

196.   Sargeant, P, Farndale RW, and Sage SO. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem 268: 18151-18156, 1993[Abstract/Free Full Text].

197.   Sargeant, P, Farndale RW, and Sage SO. The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets. FEBS Lett 315: 242-246, 1993[Web of Science][Medline].

198.   Schaller, MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, and Parsons JT. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2- dependent binding of pp60src. Mol Cell Biol 14: 1680-1688, 1994[Abstract/Free Full Text].

199.   Schindelholz, B, and Reber BFX L-type Ca2+ channels and purinergic P2X2 cation channels participate in calcium-tyrosine kinase-mediated PC12 growth cone arrest. Eur J Neurosci 12: 194-204, 2000[Web of Science][Medline].

200.   Schlaepfer, DD, Hanks SK, Hunter T, and Van Der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372: 786-791, 1994[Medline].

201.   Schlaepfer, DD, Hauck CR, and Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71: 435-478, 1999[Web of Science][Medline].

202.   Schwartz, MA, and Denninghoff K. alpha v Integrins mediate the rise in intracellular calcium in endothelial cells on fibronectin even though they play a minor role in adhesion. J Biol Chem 269: 11133-11137, 1994[Abstract/Free Full Text].

203.   Schwartz, MA, Schaller MD, and Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 11: 549-599, 1995[Web of Science][Medline].

204.   Selinfreund, RH, and Blair LA. Insulin-like growth factor-I induces a rapid increase in calcium currents and spontaneous membrane activity in clonal pituitary cells. Mol Pharmacol 45: 1215-1220, 1994[Abstract].

205.   Sharma, NR, and Davis MJ. Substance P-induced calcium entry in endothelial cells is secondary to depletion of intracellular stores. Am J Physiol Heart Circ Physiol 268: H962-H973, 1995[Abstract/Free Full Text].

206.   Sharma, NR, and Davis MJ. Calcium entry activated by store depletion in coronary endothelium is promoted by tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 270: H267-H274, 1996[Abstract/Free Full Text].

207.   Sheng, M, and Pak DT. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu Rev Physiol 62: 755-778, 2000[Web of Science][Medline].

208.   Sheng, M, and Wyszynski M. Ion channel targeting in neurons. Bioessays 19: 847-853, 1997[Web of Science][Medline].

209.   Sheng, ZH, Rettig J, Cook T, and Catterall WA. Calcium-dependent interaction of N-type calcium channels with the synaptic core complex. Nature 379: 451-454, 1996[Medline].

210.   Sheng, ZH, Rettig J, Takahashi M, and Catterall WA. Identification of a syntaxin-binding site on N-type calcium channels. Neuron 13: 1303-1313, 1994[Web of Science][Medline].

211.   Sheppard, DN, and Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 79: S23-S45, 1999.

212.   Shistik, E, Keren-Raifman T, Idelson GH, Blumenstein Y, Dascal N, and Ivanina T. The N terminus of the cardiac L-type Ca2+ channel alpha 1C subunit-the initial segment is ubiquitous and crucial for protein kinase C modulation, but is not directly phosphorylated. J Biol Chem 274: 31145-31149, 1999[Abstract/Free Full Text].

213.   Shuba, LM, and Mcdonald TF. Synergistic activation of guinea-pig cardiac cystic fibrosis transmembrane conductance regulator by the tyrosine kinase inhibitor genistein and cAMP. J Physiol (Lond) 505: 23-40, 1997[Abstract/Free Full Text].

214.   Shuba, YM, Prevarskaya N, Lemonnier L, Van Coppenolle F, Kostyuk PG, Mauroy B, and Skryma R. Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line. Am J Physiol Cell Physiol 279: C1144-C1154, 2000[Abstract/Free Full Text].

215.   Siegelbaum, SA. Channel regulation: ion channel control by tyrosine phosphorylation. Curr Biol 4: 242-245, 1994[Web of Science][Medline].

216.   Smirnov, SV, and Aaronson PI. Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638. Circ Res 76: 310-316, 1995[Abstract/Free Full Text].

217.   Smith, RD, and Goldin AL. Protein kinase A phosphorylation enhances sodium channel currents in Xenopus oocytes. Am J Physiol Cell Physiol 263: C660-C666, 1992[Abstract/Free Full Text].

218.   Snyder, PM, Cheng C, Prince LS, Rogers JC, and Welsh MJ. Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits. J Biol Chem 273: 681-684, 1998[Abstract/Free Full Text].

219.   Sobko, A, Peretz A, and Attali B. Constitutive activation of delayed-rectifier potassium channels by a Src family tyrosine kinase in Schwann cells. EMBO J 17: 4723-4734, 1998[Web of Science][Medline].

220.   Songyang, Z, Carraway KL, Iii Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, and Cantley LC. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536-539, 1995[Medline].

221.   Sorota, S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflügers Arch 431: 178-185, 1995[Web of Science][Medline].

222.   Strauss, O, Buss F, Rosenthal R, Fischer D, Mergler S, Stumpff F, and Thieme H. Activation of neuroendocrine L-type channels (alpha 1D subunits) in retinal pigment epithelial cells and brain neurons by pp60c-src. Biochem Biophys Res Commun 270: 806-810, 2000[Web of Science][Medline].

223.   Strauss, O, Mergler S, and Wiederholt M. Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells. FASEB J 11: 859-867, 1997[Abstract].

224.   Striessnig, J. Pharmacology, structure and function of cardiac L-type Ca2+ channels. Cell Physiol Biochem 9: 242-269, 1999[Web of Science][Medline].

225.   Sun, F, Hug MJ, Bradbury NA, and Frizzell RA. Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin. J Biol Chem 275: 14360-14366, 2000[Abstract/Free Full Text].

226.   Suzuki, A, Kozawa O, Saito H, and Oiso Y. Effect of prostaglandin F2 alpha on Ca2+ influx in osteoblast-like cells: function of tyrosine kinase. J Cell Biochem 54: 487-493, 1994[Web of Science][Medline].

227.   Swope, SL, and Huganir RL. Molecular cloning of two abundant protein tyrosine kinases in Torpedo electric organ that associate with the acetylcholine receptor. J Biol Chem 268: 25152-25161, 1993[Abstract/Free Full Text].

228.   Swope, SL, and Huganir RL. Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases. J Biol Chem 269: 29817-29824, 1994[Abstract/Free Full Text].

229.   Szabo, I, Gulbins E, Apfel H, Zhang X, Barth P, Busch AE, Schlottmann K, Pongs O, and Lang F. Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation. J Biol Chem 34: 20465-20469, 1996.

230.   Szücs, G, Heinke S, Degreef C, Raeymaekers L, Eggermont J, Droogmans G, and Nilius B. The volume-activated chloride current in endothelial cells from bovine pulmonary artery is not modulated by phosphorylation. Pflügers Arch 431: 540-548, 1996[Web of Science][Medline].

231.   Takeuchi, T, Kishi M, Hirayama N, Yamaji M, Ishii T, Nishio H, Hata F, and Takewaki T. Tyrosine kinase involvement in apamin-sensitive inhibitory responses of rat distal colon. J Physiol (Lond) 514: 177-188, 1999[Abstract/Free Full Text].

232.   Tezuka, T, Umemori H, Akiyama T, Nakanishi S, and Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci USA 96: 435-440, 1999[Abstract/Free Full Text].

233.   Thomas, SM, and Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609, 1997[Web of Science][Medline].

234.   Tilly, BC, Van Den Berghe N, Tertoolen LG, Edixhoven MJ, and De Jonge HR. Protein tyrosine phosphorylation is involved in osmoregulation of ionic conductances. J Biol Chem 268: 19919-19922, 1993[Abstract/Free Full Text].

235.   Timpe, LC, and Fantl WJ. Modulation of a voltage-activated potassium channel by peptide growth factor receptors. J Neurosci 14: 1195-1201, 1994[Abstract].

236.   Toma, C, Jensen PE, Prieto D, Hughes A, Mulvany MJ, and Aalkjæer C. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br J Pharmacol 114: 1266-1272, 1995[Web of Science][Medline].

237.   Toro, L, Wallner M, Meera P, and Tanaka Y. Maxi-KCa, a unique member of the voltage-gated K+ channel superfamily. News Physiol Sci 13: 112-117, 1998[Abstract/Free Full Text].

238.   Tsai, W, Morielli AD, Cachero TG, and Peralta EG. Receptor protein tyrosine phosphatase alpha  participates in the M1 muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity. EMBO J 18: 109-118, 1999[Web of Science][Medline].

239.   Tsai, W, Morielli AD, and Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 16: 4597-4605, 1997[Web of Science][Medline].

240.   Tsunoda, Y. Receptor-operated calcium influx mediated by protein tyrosine kinase pathways. J Recept Signal Transduct Res 18: 281-310, 1998[Web of Science][Medline].

241.   Tsunoda, Y, Yoshida H, Africa L, Steil GJ, and Owyang C. Src kinase pathways in extracellular Ca2+-dependent pancreatic enzyme secretion. Biochem Biophys Res Commun 227: 876-884, 1996[Web of Science][Medline].

242.   Vaca, L, and Kunze DL. Depletion of intracellular Ca2+ stores activates a Ca2+-selective channel in vascular endothelium. Am J Physiol Cell Physiol 267: C920-C925, 1994[Abstract/Free Full Text].

243.   Valenzuela, CF, Machu TK, McKernan RM, Whiting P, VanRenterghem BB, McManaman JL, Brozowski SJ, Smith GB, Olsen RW, and Harris RA. Tyrosine kinase phosphorylation of GABAA receptors. Brain Res Mol Brain Res 31: 165-172, 1995[Medline].

244.   Valverde, MA. CIC channels: leaving the dark ages on the verge of a new millennium. Curr Opin Cell Biol 11: 509-516, 1999[Web of Science][Medline].

245.   Voets, T, Manolopoulos V, Eggermont J, Ellory C, Droogmans G, and Nilius B. Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins. J Physiol (Lond) 506: 341-352, 1998[Abstract/Free Full Text].

246.   Vostal, JG, Jackson WL, and Shulman NR. Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem 266: 16911-16916, 1991[Abstract/Free Full Text].

247.   Vuori, K. Integrin signaling: tyrosine phosphorylation events in focal adhesions. J Membr Biol 165: 191-199, 1998[Web of Science][Medline].

248.   Waitkus, KR, Davis GE, and Meininger GA. Collagen proteolysis and vasodilation in isolated rat cremaster arterioles (Abstract). FASEB J 12: A384, 1998.

249.   Walton, KM, and Dixon JE. Protein tyrosine phosphatases. Annu Rev Biochem 62: 101-120, 1993[Web of Science][Medline].

250.   Wan, Q, Man HY, Braunton J, Wang W, Salter MW, Becker L, and Wang YT. Modulation of GABAA receptor function by tyrosine phosphorylation of beta  subunits. J Neurosci 17: 5062-5069, 1997[Abstract/Free Full Text].

251.   Wang, W. Regulation of the ROMK channel: interaction of the ROMK with associate proteins. Am J Physiol Renal Physiol 277: F826-F831, 1999[Abstract/Free Full Text].

252.   Wang, YG, and Lipsius SL. Genistein elicits biphasic effects on L-type Ca2+ current in feline atrial myocytes. Am J Physiol Heart Circ Physiol 275: H204-H212, 1998[Abstract/Free Full Text].

253.   Wang, YT, and Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369: 233-235, 1994[Medline].

254.   Wang, YT, Yu XM, and Salter MW. Ca2+-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc Natl Acad Sci USA 93: 1721-1725, 1996[Abstract/Free Full Text].

255.   Wang, Z, Estacion M, and Mordan LJ. Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol Cell Physiol 265: C1239-C1246, 1993[Abstract/Free Full Text].

256.   Wang, ZW, and Kotlikoff MI. Activation of KCa channels in airway smooth muscle cells by endogenous protein kinase A. Am J Physiol Lung Cell Mol Physiol 271: L100-L105, 1996[Abstract/Free Full Text].

257.   Watson, CL, and Gold MR. Lysophosphatidylcholine modulates cardiac INa via multiple protein kinase pathways. Circ Res 81: 387-395, 1997[Abstract/Free Full Text].

258.   Wei, X, Neely A, Lacerda AE, Olcese R, Stefani E, Perez-Reyes E, and Birnbaumer L. Modification of Ca2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunit. J Biol Chem 269: 1635-1640, 1994[Abstract/Free Full Text].

259.   Wes, PD, Chevesich J, Jeromin A, Rosenberg C, Stetten G, and Montell C. TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci USA 92: 9652-9656, 1995[Abstract/Free Full Text].

260.   Wijetunge, S, Aalkjaer C, Schachter M, and Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189: 1620-1623, 1992[Web of Science][Medline].

261.   Wijetunge, S, and Hughes AD. Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells. Br J Pharmacol 115: 534-538, 1995[Web of Science][Medline].

262.   Wijetunge, S, and Hughes AD. pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 217: 1039-1044, 1995[Web of Science][Medline].

263.   Wijetunge, S, and Hughes AD. Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells. FEBS Lett 399: 63-66, 1996[Web of Science][Medline].

264.   Wijetunge, S, Lymn JS, and Hughes AD. Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells. Br J Pharmacol 124: 307-316, 1998[Web of Science][Medline].

265.   Wijetunge, S, Lymn JS, and Hughes AD. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60c-src kinase activity. Br J Pharmacol 129: 1347-1354, 2000[Web of Science][Medline].

266.   Wildering, WC, Lodder JC, Kits KS, and Bulloch AG. Nerve growth factor (NGF) acutely enhances high-voltage-activated calcium currents in molluscan neurons. J Neurophysiol 74: 2778-2781, 1995[Abstract/Free Full Text].

267.   Wilson, GF, and Kaczmarek LK. Mode-switching of a voltage-gated cation channel is mediated by a protein kinase A-regulated tyrosine phosphatase. Nature 366: 433-438, 1993[Medline].

268.   Wischmeyer, E, Doring F, and Karschin A. Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation. J Biol Chem 273: 34063-34068, 1998[Abstract/Free Full Text].

269.   Wiser, O, Trus M, Hernandez A, Renstrom E, Barg S, Rorsman P, and Atlas D. The voltage sensitive L-type Ca2+ channel is functionally coupled to the exocytotic machinery. Proc Natl Acad Sci USA 96: 248-253, 1999[Abstract/Free Full Text].

270.  Wu X, Davis GE, Meininger GA, Wilson E, and Davis MJ. Regulation of the L-type calcium channel by alpha 5beta 1 integrin requires signaling between focal adhesion proteins. J Biol Chem 29: 2001. In press.

271.   Wu, X, Mogford JE, Platts SH, Davis GE, Meininger GA, and Davis MJ. Modulation of calcium current in arteriolar smooth muscle by alpha vbeta 3 and alpha 5beta 1 integrin ligands. J Cell Biol 143: 241-252, 1998[Abstract/Free Full Text].

272.   Wyszynski, M, Lin J, Rao A, Nigh E, Beggs AH, Craig AM, and Sheng M. Competitive binding of alpha -actinin and calmodulin to the NMDA receptor. Nature 385: 439-442, 1997[Medline].

273.   Xu, XZ, Choudhury A, Li X, and Montell C. Coordination of an array of signaling proteins through homo- and heteromeric interactions between PDZ domains and target proteins. J Cell Biol 142: 545-555, 1998[Abstract/Free Full Text].

274.   Yokoshiki, H, Sumii K, and Sperelakis N. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 28: 807-814, 1996[Web of Science][Medline].

275.   Yu, XM, Askalan R, Keil GJ, II, and Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275: 674-678, 1997[Abstract/Free Full Text].

276.   Yule, DI, Kim ET, and Williams JA. Tyrosine kinase inhibitors attenuate "capacitative" Ca2+ influx in rat pancreatic acinar cells. Biochem Biophys Res Commun 202: 1697-1704, 1994[Web of Science][Medline].

277.   Zagotta, WN, and Siegelbaum SA. Structure and function of cyclic nucleotide-gated channels. Annu Rev Neurosci 19: 235-263, 1996[Web of Science][Medline].

278.   Zhang, ZH, and Wang Q. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein. Pflügers Arch 440: 784-792, 2000[Web of Science][Medline].

279.   Zheng, X, Zhang L, Wang AP, Bennett MV, and Zukin RS. Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. Proc Natl Acad Sci USA 96: 15262-15267, 1999[Abstract/Free Full Text].

280.   Zhou, WL, Sugioka M, Sakaki Y, and Yamashita M. Regulation of capacitative Ca2+ entry by tyrosine phosphorylation in the neural retina of chick embryo. Neurosci Lett 272: 123-126, 1999[Web of Science][Medline].

281.   Zitt, C, Zobel A, Obukhov AG, Harteneck C, Kalkbrenner F, Luckhoff A, and Schultz G. Cloning and functional expression of a human Ca2+-permeable cation channel activated by calcium store depletion. Neuron 16: 1189-1196, 1996[Web of Science][Medline].

282.   Zuckerman, JB, Chen X, Jacobs JD, Hu B, Kleyman TR, and Smith PR. Association of the epithelial sodium channel with Apx and alpha -spectrin in A6 renal epithelial cells. J Biol Chem 274: 23286-23295, 1999[Abstract/Free Full Text].

283.   Zweifach, A, and Lewis RS. Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores. Proc Natl Acad Sci USA 90: 6295-6299, 1993[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 281(5):H1835-H1862
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Chen and R. A. Khalil
Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Jeulin, V. Seltzer, D. Bailbe, K. Andreau, and F. Marano
EGF mediates calcium-activated chloride channel activation in the human bronchial epithelial cell line 16HBE14o-: involvement of tyrosine kinase p60c-src
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L489 - L496.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. J. Sjostrom, E. A. Rancz, A. Roth, and M. Hausser
Dendritic Excitability and Synaptic Plasticity
Physiol Rev, April 1, 2008; 88(2): 769 - 840.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
V. Hinard, D. Belin, S. Konig, C. R. Bader, and L. Bernheim
Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242
Development, March 1, 2008; 135(5): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C.-H. Li, Q. Zhang, B. Teng, S. J. Mustafa, J.-Y. Huang, and H.-G. Yu
Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C355 - C362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Kang, G. R. Ross, and H. I. Akbarali
COOH-terminal association of human smooth muscle calcium channel Cav1.2b with Src kinase protein binding domains: effect of nitrotyrosylation
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1983 - C1990.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Abriel
Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies
Cardiovasc Res, December 1, 2007; 76(3): 381 - 389.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
S.-S. Zhou, L.-B. Zhang, W.-P. Sun, F.-C. Xiao, Y.-M. Zhou, Y.-J. Li, and D.-L. Li
Heart/Cardiac Muscle: Effects of monocarboxylic acid-derived Cl- channel blockers on depolarization-activated potassium currents in rat ventricular myocytes
Exp Physiol, May 1, 2007; 92(3): 549 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Missan, P. Linsdell, and T. F. McDonald
Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes
J. Physiol., June 1, 2006; 573(2): 469 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zong, C. Eckert, H. Yuan, C. Wahl-Schott, H. Abicht, L. Fang, R. Li, P. Mistrik, A. Gerstner, B. Much, et al.
A Novel Mechanism of Modulation of Hyperpolarization-activated Cyclic Nucleotide-gated Channels by Src Kinase
J. Biol. Chem., October 7, 2005; 280(40): 34224 - 34232.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Chittajallu, A. A. Aguirre, and V. Gallo
Downregulation of Platelet-Derived Growth Factor-{alpha} Receptor-Mediated Tyrosine Kinase Activity as a Cellular Mechanism for K+-Channel Regulation during Oligodendrocyte Development In Situ
J. Neurosci., September 21, 2005; 25(38): 8601 - 8610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. I. Akbarali
Signal-Transduction Pathways that Regulate Smooth Muscle Function II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle
Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G598 - G602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Ling, J.-Z. Sheng, and A. P. Braun
The calcium-dependent activity of large-conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced tyrosine phosphorylation
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C698 - C706.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Nesti, B. Everill, and A. D. Morielli
Endocytosis as a Mechanism for Tyrosine Kinase-dependent Suppression of a Voltage-gated Potassium Channel
Mol. Biol. Cell, September 1, 2004; 15(9): 4073 - 4088.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Jin, N. Morsy, J. Winston, P. J. Pasricha, K. Garrett, and H. I. Akbarali
Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C558 - C563.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. V. Bobkov and B. W. Ache
Calcium Sensitivity of a Sodium-Activated Nonselective Cation Channel in Lobster Olfactory Receptor Neurons
J Neurophysiol, November 1, 2003; 90(5): 2928 - 2940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. E. Belevych, S. Warrier, and R. D. Harvey
Genistein Inhibits Cardiac L-Type Ca2+ Channel Activity by a Tyrosine Kinase-Independent Mechanism
Mol. Pharmacol., September 1, 2002; 62(3): 554 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Byron and P. A. Lucchesi
Signal Transduction of Physiological Concentrations of Vasopressin in A7r5 Vascular Smooth Muscle Cells. A ROLE FOR PYK2 AND TYROSINE PHOSPHORYLATION OF K+ CHANNELS IN THE STIMULATION OF Ca2+ SPIKING
J. Biol. Chem., February 22, 2002; 277(9): 7298 - 7307.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (43)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, M. J.
Right arrow Articles by Wilson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, M. J.
Right arrow Articles by Wilson, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online